{
    "en_vn": {
        "data": {
            "content": null,
            "word": "prednisone",
            "pronounce": ""
        }
    },
    "en_en": {
        "data": {
            "content": "<div class=\"dict--title\">Anh - Anh</div><div class=\"dict--content\"><k>prednisone</k><blockquote><cclass>[<cclass>'pr\u025bdn\u026az\u0259\u028an<cclass>]</cclass></cclass></cclass></blockquote><blockquote>\u25a0 <cclass>noun <cclass>Medicine a synthetic drug similar to cortisone, used to relieve rheumatic and allergic conditions and to treat leukaemia. </cclass></cclass></blockquote><blockquote/><blockquote><b><cclass>Origin</cclass></b></blockquote><blockquote>1950s: perh. from <i>pre(gnane)</i> (a synthetic hydrocarbon) + <i>d(ie)n(e)</i> + <i>(cort)isone</i>. </blockquote></div>",
            "word": "prednisone",
            "pronounce": ""
        }
    },
    "synonyms": {
        "data": {
            "content": null,
            "word": "prednisone",
            "pronounce": ""
        }
    },
    "grammar": {
        "data": {
            "content": null,
            "word": "prednisone",
            "pronounce": ""
        }
    },
    "specialist": {
        "data": {
            "content": null,
            "word": "prednisone",
            "pronounce": ""
        }
    },
    "sentences": [
        {
            "en": "Drugs used in the treatment of the disease include nitrogen mustard, vincristine, procarbazine, <em>prednisone</em>, chlorambucil, and vinblastine.",
            "vi": "Thu\u1ed1c d\u00f9ng \u0111i\u1ec1u tr\u1ecb b\u1ec7nh g\u1ed3m m\u00f9 t\u1ea1c nit\u01a1, vincristine, procarbazine, prednisone, chlorambucil, v\u00e0 vinblastine."
        },
        {
            "en": "CorticosteroidsAnti-inflammatory steroid medications like <em>prednisone</em> are notorious for causing weight gain. Fluid retention and increased appetite are the main reasons. Although weight gain is common, the severity of this side effect depends on the strength of the dose and length of time on the drug. Some people may also see a redistribution of fat while taking the drug -- to places like the face, back of the neck, or the abdomen.",
            "vi": "C\u00e1c lo\u1ea1i thu\u1ed1c CorticosteroidC\u00e1c lo\u1ea1i thu\u1ed1c steroid kh\u00e1ng vi\u00eam ch\u1eb3ng h\u1ea1n nh\u01b0 prednisone n\u1ed5i ti\u1ebfng l\u00e0 g\u00e2y t\u0103ng c\u00e2n. Nguy\u00ean nh\u00e2n ch\u00ednh l\u00e0 t\u00ecnh tr\u1ea1ng phu\u0300 n\u1ec1 v\u00e0 l\u00e0m cho b\u1ec7nh nh\u00e2n \u0103n ngon mi\u1ec7ng h\u01a1n. M\u1eb7c du\u0300 t\u0103ng c\u00e2n l\u00e0 y\u1ebfu t\u1ed1 th\u01b0\u1eddng th\u1ea5y nh\u01b0ng m\u1ee9c \u0111\u1ed9 nghi\u00eam tr\u1ecdng c\u1ee7a t\u00e1c d\u1ee5ng ph\u1ee5 n\u00e0y tu\u0300y thu\u1ed9c v\u00e0o li\u1ec1u l\u01b0\u1ee3ng v\u00e0 th\u1eddi gian s\u1eed d\u1ee5ng thu\u1ed1c l\u00e0 bao l\u00e2u. M\u1ed9t s\u1ed1 ng\u01b0\u1eddi cu\u0303ng c\u00f3 th\u1ec3 ph\u00e1t hi\u1ec7n ra l\u01b0\u1ee3ng m\u1ee1 tr\u00ean c\u01a1 th\u1ec3 m\u00ecnh c\u00f3 s\u1ef1 ph\u00e2n b\u1ed1 l\u1ea1i khi s\u1eed d\u1ee5ng thu\u1ed1c \u2013 ch\u1eb3ng h\u1ea1n nh\u01b0 m\u1eb7t, sau c\u1ed5, ho\u1eb7c b\u1ee5ng."
        },
        {
            "en": "Eczema treatment \u2013 Medications  Corticosteroid creams are sometimes prescribed to decrease the inflammatory reaction in the skin. These may be mild-, medium-, or high-potency corticosteroid creams depending upon the severity of the symptoms. If itching is severe, oral antihistamines may be prescribed. To control itching, the sedative type antihistamine drugs (for example, diphenhydramine [Benadryl], hydroxyzine [Atarax, Vistaril], and cyproheptadine) appear to be most effective. In some cases, a short course of oral corticosteroids (such as <em>prednisone</em>) is prescribed to control an acute outbreak of eczema, although their long-term use is discouraged in the treatment of this non-life-threatening condition because of unpleasant and potentially harmful side effects.",
            "vi": "\u0110i\u1ec1u tr\u1ecb ch\u00e0m b\u1eb1ng thu\u1ed1c   Kem corticosteroid \u0111\u00f4i khi \u0111\u01b0\u1ee3c k\u00ea toa \u0111\u1ec3 l\u00e0m gi\u1ea3m ph\u1ea3n \u1ee9ng vi\u00eam \u1edf da. Chu\u0301ng c\u00f3 th\u1ec3 l\u00e0 nh\u1eefng lo\u1ea1i kem c\u00f3 h\u00e0m l\u01b0\u1ee3ng corticosteroid th\u1ea5p, trung b\u00ecnh, ho\u1eb7c cao tu\u1ef3 v\u00e0o m\u1ee9c \u0111\u1ed9 nghi\u00eam tr\u1ecdng c\u1ee7a tri\u1ec7u ch\u1ee9ng. N\u1ebfu b\u1ec7nh nh\u00e2n ng\u1ee9a d\u1eef d\u1ed9i th\u00ec b\u00e1c s\u0129 c\u00f3 th\u1ec3 k\u00ea toa cho s\u1eed d\u1ee5ng thu\u1ed1c kh\u00e1ng histamine d\u1ea1ng u\u1ed1ng. \u0110\u1ec3 gi\u1ea3m ng\u1ee9a, th\u00ec nh\u1eefng lo\u1ea1i thu\u1ed1c kh\u00e1ng histamine gi\u1ea3m \u0111au (ch\u1eb3ng h\u1ea1n nh\u01b0 diphenhydramine [Benadryl], hydroxyzine [Atarax, Vistaril], v\u00e0 cyproheptadine) c\u00f3 v\u1ebb hi\u1ec7u qu\u1ea3 nh\u1ea5t. Trong m\u1ed9t v\u00e0i tr\u01b0\u1eddng h\u1ee3p, b\u00e1c s\u0129 c\u00f3 th\u1ec3 k\u00ea toa cho s\u1eed d\u1ee5ng thu\u1ed1c corticosteroid d\u1ea1ng u\u1ed1ng (ch\u1eb3ng h\u1ea1n nh\u01b0 prednisone) trong m\u1ed9t th\u1eddi gian ng\u1eafn \u0111\u1ec3 l\u00e0m gi\u1ea3m bu\u0300ng ph\u00e1t ch\u00e0m c\u1ea5p t\u00ednh, m\u1eb7c du\u0300 vi\u1ec7c s\u1eed d\u1ee5ng l\u00e2u d\u00e0i kh\u00f4ng \u0111\u01b0\u1ee3c khuy\u1ebfn kh\u00edch \u0111\u1ed1i v\u1edbi ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb ch\u1ee9ng b\u1ec7nh kh\u00f4ng nguy hi\u1ec3m \u0111\u1ebfn t\u00ednh m\u1ea1ng n\u00e0y b\u1edfi nhi\u1ec1u t\u00e1c d\u1ee5ng ph\u1ee5 kh\u00f3 ch\u1ecbu v\u00e0 c\u00f3 h\u1ea1i c\u00f3 th\u1ec3 x\u1ea3y ra.\u00a0"
        },
        {
            "en": "st1\\:*{behavior:url(#ieooui) }     What is osteoporosis? Osteoporosis is a disease characterized by low bone mass and loss of bone tissue that may lead to weak and fragile bones. If you have osteoporosis, you have an increased risk for fractured bones (broken bones).  Does osteoporosis only affect the elderly?  Osteoporosis has often been thought to be a condition that frail elderly women develop. However, the damage from osteoporosis begins much earlier in life. Because peak bone density is reached at approximately 25 years of age, it is important to build strong bones by that age, so that the bones will remain strong later in life. Adequate calcium intake and exercise are essential for building strong bones. Why is osteoporosis an important public health issue? In the United States, more than 10 million people have osteoporosis and almost 34 million more have low bone density. Approximately 80% of those with osteoporosis are women. Of people older than 50 years of age, one in two women and one in eight men are predicted to have an osteoporosis-related fracture in their lifetime. White and Asian racial groups are at a greater risk. With the aging of America, the number of people with osteoporosis-related fractures will increase substantially. The pain, suffering, and economic costs will be enormous. What are the symptoms of osteoporosis? Normal bone is composed of protein, collagen, and calcium, all of which give bone its strength. Bones that are affected by osteoporosis can break (fracture) with relatively minor injury that normally would not cause a bone to fracture. The osteoporosis condition can be present without any symptoms for decades. Therefore, patients may not be aware of their osteoporosis until they suffer a painful fracture. Symptoms depend on the location of the fracture. We'll take a look at the most common locations for osteoporotic fractures on the next few slides. Osteoporosis symptoms: Fractures of the spine Fractures of the spine (vertebra) can cause severe \"band-like\" pain that radiates around from the back to the side of the body. Over the years, repeated spine fractures can cause chronic lower back pain as well as loss of height or curving of the spine, which gives the individual a hunched-back appearance of the upper back, referred to as a \"dowager hump.\" Osteoporosis symptoms: Stress fracture A fracture that occurs during the course of normal activity is called a minimal trauma fracture or stress fracture. For example, some patients with osteoporosis develop stress fractures of the feet while walking or stepping off a curb.  Osteoporosis symptoms: Hip fracture Hip fractures typically occur as a result of a fall. With osteoporosis, hip fractures can occur as a result of trivial accidents. Hip fractures may also be difficult to heal after surgical repair because of poor bone quality. What are the consequences of osteoporosis? Osteoporosis bone fractures are responsible for considerable pain, decreased quality of life, lost workdays, and disability. Up to 30% of patients suffering a hip fracture will require long-term nursing-home care. Some 20% of women with a hip fracture will die in the subsequent year as an indirect result of the fracture. In addition, once a person has experienced a spine fracture due to osteoporosis, he or she is at very high risk of suffering another such fracture in the near future (next few years).  What factors determine bone strength? Bone mass (bone density) is the amount of bone present in the skeletal structure. Generally, the higher the bone density, the stronger the bones. Bone density is greatly influenced by genetic factors and can be affected by environmental factors and medications. For example, men have a higher bone density than women. African Americans have a higher bone density than Caucasian or Asian Americans. Normally, bone density accumulates during childhood and reaches a peak by around 25 years of age. Bone density is then maintained for about 10 years. After age 35, both men and women will normally lose 0.3%-0.5% of their bone density per year as part of the aging process. Menopause, Estrogen, and Osteoporosis Estrogen is important in maintaining bone density in women. When estrogen levels drop after menopause, bone loss accelerates. During the first five to 10 years after menopause, women can suffer up to 2%-4% loss of bone density per year! This can result in the loss of up to 25%-30% of their bone density during that time period. Accelerated bone loss after menopause is a major cause of osteoporosis in women. What are the risk factors for developing osteoporosis? * female gender  * Caucasian or Asian race  * thin and small body frames  * family history of osteoporosis (for example, having a mother with an osteoporotic hip fracture doubles your risk of hip fracture)  * personal history of fracture as an adult  * cigarette smoking  * excessive alcohol consumption  * lack of exercise  * diet low in calcium  * poor nutrition and poor general health  * malabsorption (nutrients in the bowels are not properly absorbed)  * low estrogen levels  * chemotherapy  * loss of the menstrual period (amenorrhea)  * chronic inflammation  * immobility, such as after a stroke or any condition that interferes with walking  * hyperthyroidism (excessive thyroid hormone)  * hyperparathyroidism (excessive parathyroid hormone production causes too much calcium to be removed from the bone)  * vitamin D deficiency (vitamin D helps the body absorb calcium)  * certain medications can cause osteoporosis such as long-term use of heparin (a blood thinner), antiseizure medications phenytoin (Dilantin) and phenobarbital, and long-term use of oral corticosteroids (such as <em>prednisone</em>)   How is osteoporosis diagnosed? A routine X-ray can suggest osteoporosis of the bone, which appears much thinner and lighter than normal bones. Unfortunately, by the time X-rays can detect osteoporosis, at least 30% of the bone has already been lost. In addition, X-rays are not accurate indicators of bone density. The appearance of the bone on the X-ray is often affected by variations in the degree of exposure of the X-ray film.  The National Osteoporosis Foundation, the American Medical Association, and other major medical organizations are recommending a dual energy X-ray absorptiometry (DEXA or DXA) for diagnosing osteoporosis. The test measures bone density in the hip and the spine, takes only five to 15 minutes to perform, uses very little radiation (less than one-tenth to one-hundredth the amount used on a standard chest X-ray), and is quite precise. Who should have bone density testing? The national osteoporosis foundation guidelines state that there are several groups of people who should consider DXA testing: * all postmenopausal women below age 65 who have risk factors for osteoporosis;  * all women aged 65 and older;  * postmenopausal women with fractures, although this is not mandatory because treatment may be started regardless of bone density; * women with one of the many medical conditions associated with osteoporosis   How are bone density results measured?  Upon completion of a DXA scan, the bone density of the patient is then compared to the average peak bone density of young adults of same sex and race. This score is called the \"T score,\" and it expresses the bone density in terms of the number of standard deviations (SD).  * Osteoporosis is defined as a bone density T score of -2.5 SD or below.  * Osteopenia (between normal and osteoporosis) is defined as a bone density T score between -1 and -2.5 SD for all women aged 65 and older;  How is osteoporosis treated and prevented? The goal of osteoporosis treatment is the prevention of bone fractures by stopping bone loss and by increasing bone density and strength. Although early detection and timely treatment of osteoporosis can substantially decrease the risk of future fracture, none of the available treatments for osteoporosis are complete cures. In other words, it is difficult to completely rebuild bone that has been weakened by osteoporosis. Therefore, prevention of osteoporosis is as important as treatment. We'll take a look at some of the prevention and treatment options on the following slides. Prevention and treatment: Exercise Exercise has a wide variety of beneficial health effects. However, exercise does not bring about substantial increases in bone density. The benefit of exercise for osteoporosis has mostly to do with decreasing the risk of falls, probably because balance is improved and/or muscle strength is increased. Research has not yet precisely determined what type or duration of exercise is best for osteoporosis. Nevertheless, most doctors recommend weight-bearing exercise, walking, preferably daily. A word of caution about exercise It is important to avoid exercises that can injure already weakened bones. In patients over 40 and those with heart disease, obesity, diabetes mellitus, and high blood pressure, exercise should be prescribed and monitored by their doctors. Finally, extreme levels of exercise (such as marathon running) may not be healthy for the bones. Marathon running in young women that leads to weight loss and loss of menstrual periods can actually cause osteoporosis. Prevention and treatment: Quit smoking and curtail alcohol Smoking one pack of cigarettes per day throughout adult life can itself lead to loss of 5%-10% of bone mass. Smoking cigarettes decreases estrogen levels and can lead to bone loss in women before menopause. Smoking cigarettes can also lead to earlier menopause. Data on the effect of regular consumption of alcohol and caffeine on osteoporosis is not as clear as with exercise and cigarettes. In fact, research regarding alcohol and caffeine as risk factors for osteoporosis shows widely varying results and is controversial. Certainly, these effects are not as powerful as other factors. Nonetheless, moderation of both alcohol and caffeine is prudent. Prevention and treatment: Calcium supplements Building strong and healthy bones requires an adequate dietary intake of calcium and exercise beginning in childhood and adolescence for both sexes. Importantly, once osteoporosis is present, a high dietary calcium intake or taking calcium supplements alone is not sufficient in treating osteoporosis and should not be viewed as an alternative to or substituted for more potent prescription osteoporosis medications. In the first several years after menopause, rapid bone loss can occur even if calcium supplements are taken. Unfortunately, surveys have shown that the average woman in the United States consumes less than 500 milligrams of calcium per day in her diet, less than the recommended amounts. Additional calcium can be obtained by drinking more milk and eating more yogurt or cottage cheese or by taking calcium supplement tablets as well from calcium-fortified foods, such as orange juice.  Prevention and treatment: Calcium-fortified foods Excluding dairy products, the average American diet contains approximately 250 mg of calcium. As mentioned on the previous slide, here are some examples of calcium-fortified foods and their respective calcium intake. Prevention and treatment: Vitamin D An adequate calcium intake and adequate body stores of vitamin D are important foundations for maintaining bone density and strength. Unfortunately, vitamin D deficiency is quite common in the United States. Vitamin D is important in several respects:  * vitamin D helps the absorption of calcium from the intestines;  * a lack of vitamin D causes calcium-depleted bone (osteomalacia), which further weakens the bones and increases the risk of fractures; and  * vitamin D, along with adequate calcium (1,200 mg of elemental calcium), has been shown in some studies to increase bone density and decrease fractures in older postmenopausal but not in premenopausal or perimenopausal women.  The food and nutrition board of the Institute of Medicine has recommended the following as an as adequate vitamin D intake: * 200 IU daily for men and women 19 to 50 years old;  * 400 IU daily for men and women 51 to 70 years old; and  * IU daily for men and women 71 years and older.  Good sources of vitamin D include natural sunlight, fortified milk, cheese, butter/margarine, cereal, and fish. Prevention and treatment: Menopausal hormone therapy  Menopausal hormone therapy (previously referred to as hormone replacement therapy or HRT) has been shown to prevent bone loss, increase bone density, and prevent bone fractures. Estrogen is available orally (Premarin, Estrace, Estratest, and others) or as a skin patch (Estraderm, Vivelle, and others). Estrogen is also available in combination with progesterone as pills and patches. Progesterone is routinely given along with estrogen to prevent uterine cancer that might result from estrogen use alone. Women who have had a hysterectomy (surgical removal of the uterus) may take estrogen alone. Due to adverse effects of menopausal hormone therapy, such as increased risks of heart attack, stroke, blood clots in the veins, and breast cancer; menopausal hormone therapy is no longer recommended for long-term use but rather short-term use to relieve menopausal hot flashes. Every woman should have an individualized discussion regarding estrogen replacement with her doctor. Prevention and treatment: Medications Currently, the most effective medications for osteoporosis that are approved by the FDA are anti-resorptive agents, which prevent bone breakdown. Antiresorptive medications inhibit bone removal (resorption), thus leading to bone rebuilding and increasing bone density. Menopausal estrogen hormone therapy is one example of an antiresorptive agent. Others include alendronate (Fosamax), risedronate (Actonel), raloxifene (Evista), ibandronate (Boniva), calcitonin (Calcimar), and zoledronate (Reclast). Prevention of hip fractures The FDA has approved hip-protector garments for the prevention of hip fractures in unstable elderly people with known osteoporosis. Brand names available include Hipsaver and Safehip. These can be helpful for patients who are in the nursing-home environment, although the real extent of protection against hip fractures that is gained with use of hip protectors is a matter of current controversy. Osteoporosis at a glance * Osteoporosis is a condition of increased susceptibility to fracture due to fragile bone.  * Osteoporosis weakens bone and increases risk of bone fracture.  * Bone mass (bone density) decreases after age 35 years and decreases more rapidly in women after menopause. * Key risk factors for osteoporosis include genetic factors, lack of exercise, lack of calcium and vitamin D, personal history of fracture as an adult, rheumatoid arthritis, cigarette smoking, excessive alcohol consumption, low body weight, and family history of osteoporosis. * Patients with osteoporosis have no symptoms until bone fractures occur.  * Diagnosis can be suggested by X-rays and confirmed by using tests to measure bone density.  * Treatments for osteoporosis, in addition to prescription osteoporosis medications, include stopping use of alcohol and cigarettes, and assuring adequate exercise, calcium, and vitamin D.",
            "vi": "Lo\u00e3ng x\u01b0\u01a1ng l\u00e0 g\u00ec? Lo\u00e3ng x\u01b0\u01a1ng l\u00e0 b\u1ec7nh \u0111\u1eb7c tr\u01b0ng b\u1edfi kh\u1ed1i l\u01b0\u1ee3ng x\u01b0\u01a1ng th\u1ea5p v\u00e0 m\u1ea5t m\u00f4 x\u01b0\u01a1ng c\u00f3 th\u1ec3 l\u00e0m cho x\u01b0\u01a1ng y\u1ebfu v\u00e0 d\u1ec5 g\u00e3y. N\u1ebfu b\u1ea1n b\u1ecb lo\u00e3ng x\u01b0\u01a1ng, th\u00ec nguy c\u01a1 b\u1ea1n b\u1ecb g\u00e3y x\u01b0\u01a1ng t\u0103ng cao.  C\u00f3 ph\u1ea3i ch\u1ee9ng lo\u00e3ng x\u01b0\u01a1ng ch\u1ec9 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn ng\u01b0\u1eddi gi\u00e0? Ng\u01b0\u1eddi ta th\u01b0\u1eddng \u0111\u00e3 cho r\u1eb1ng b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng l\u00e0 ch\u1ee9ng b\u1ec7nh x\u1ea3y ra \u1edf ph\u1ee5 n\u1eef \u1ed1m y\u1ebfu l\u1edbn tu\u1ed5i. Tuy nhi\u00ean, t\u1ed5n th\u01b0\u01a1ng do lo\u00e3ng x\u01b0\u01a1ng g\u00e2y ra b\u1eaft \u0111\u1ea7u r\u1ea5t s\u1edbm. Do m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng cao nh\u1ea5t l\u00e0 \u1edf kho\u1ea3ng 25 tu\u1ed5i, n\u00ean quan tr\u1ecdng l\u00e0 ph\u1ea3i l\u00e0m cho x\u01b0\u01a1ng ch\u1eafc kh\u1ecfe \u1edf \u0111\u1ed9 tu\u1ed5i n\u00e0y, sao cho x\u01b0\u01a1ng v\u1eabn c\u00f2n c\u1ee9ng c\u00e1p v\u1ec1 sau. Luy\u1ec7n t\u1eadp th\u1ec3 d\u1ee5c v\u00e0 b\u1ed5 sung can-xi \u0111\u1ea7y \u0111\u1ee7 l\u00e0 \u0111i\u1ec1u quan tr\u1ecdng \u0111\u1ec3 giu\u0301p cho x\u01b0\u01a1ng \u0111\u01b0\u1ee3c ch\u1eafc kh\u1ecfe. T\u1ea1i sao b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng l\u00e0 m\u1ed9t v\u1ea5n \u0111\u1ec1 quan tr\u1ecdng c\u1ee7a ng\u00e0nh y t\u1ebf c\u1ed9ng \u0111\u1ed3ng?  C\u00f3 h\u01a1n 10 tri\u1ec7u ng\u01b0\u1eddi M\u1ef9 b\u1ecb lo\u00e3ng x\u01b0\u01a1ng v\u00e0 g\u1ea7n 34 tri\u1ec7u ng\u01b0\u1eddi c\u00f3 m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng th\u1ea5p. Kho\u1ea3ng 80% b\u1ec7nh nh\u00e2n b\u1ecb lo\u00e3ng x\u01b0\u01a1ng l\u00e0 ph\u1ee5 n\u1eef. \u0110\u1ed1i v\u1edbi ng\u01b0\u1eddi gi\u00e0 tr\u00ean 50 tu\u1ed5i, t\u1ec9 l\u1ec7 b\u1ec7nh nh\u00e2n b\u1ecb d\u1ef1 \u0111o\u00e1n n\u1ee9t x\u01b0\u01a1ng do lo\u00e3ng x\u01b0\u01a1ng g\u00e2y ra l\u00e0 1:2 \u1edf n\u1eef v\u00e0 1:8 \u1edf nam trong su\u1ed1t cu\u1ed9c \u0111\u1eddi m\u00ecnh. C\u00e1c nh\u00f3m ng\u01b0\u1eddi thu\u1ed9c ch\u1ee7ng t\u1ed9c da tr\u1eafng v\u00e0 ch\u00e2u \u00c1 c\u00f3 nguy c\u01a1 b\u1ecb lo\u00e3ng x\u01b0\u01a1ng cao h\u01a1n. S\u1ed1 ng\u01b0\u1eddi b\u1ecb n\u1ee9t x\u01b0\u01a1ng do lo\u00e3ng x\u01b0\u01a1ng g\u00e2y ra t\u0103ng nhanh \u0111\u00e1ng k\u1ec3 \u0111\u1ed1i v\u1edbi ng\u01b0\u1eddi gi\u00e0 \u1edf M\u1ef9. Lo\u00e3ng x\u01b0\u01a1ng l\u00e0m cho b\u1ec7nh nh\u00e2n \u0111au \u0111\u1edbn, kh\u1ed5 s\u1edf v\u00e0 t\u1ed1n k\u00e9m r\u1ea5t nhi\u1ec1u.  Tri\u1ec7u ch\u1ee9ng c\u1ee7a lo\u00e3ng x\u01b0\u01a1ng l\u00e0 g\u00ec? X\u01b0\u01a1ng th\u01b0\u1eddng \u0111\u01b0\u1ee3c c\u1ea5u t\u1ea1o t\u1eeb pr\u00f4-t\u00ea-in, collagen (ch\u1ea5t t\u1ea1o keo), v\u00e0 can-xi, t\u1ea5t c\u1ea3 l\u00e0m cho x\u01b0\u01a1ng tr\u1edf n\u00ean ch\u1eafc kh\u1ecfe. Lo\u00e3ng x\u01b0\u01a1ng c\u00f3 th\u1ec3 l\u00e0m cho x\u01b0\u01a1ng b\u1ecb g\u00e3y (n\u1ee9t) do ch\u1ea5n th\u01b0\u01a1ng kh\u00e1 nh\u1eb9 m\u00e0 b\u00ecnh th\u01b0\u1eddng s\u1ebd kh\u00f4ng l\u00e0m cho x\u01b0\u01a1ng g\u00e3y n\u1ee9t.  B\u1ec7nh nh\u00e2n b\u1ecb lo\u00e3ng x\u01b0\u01a1ng c\u00f3 th\u1ec3 kh\u00f4ng bi\u1ec3u hi\u1ec7n tri\u1ec7u ch\u1ee9ng g\u00ec trong th\u1eddi gian d\u00e0i. Do \u0111\u00f3, ng\u01b0\u1eddi b\u1ec7nh c\u00f3 th\u1ec3 kh\u00f4ng bi\u1ebft m\u00ecnh b\u1ecb lo\u00e3ng x\u01b0\u01a1ng cho \u0111\u1ebfn khi b\u1ecb n\u1ee9t x\u01b0\u01a1ng g\u00e2y \u0111au \u0111\u1edbn. C\u00e1c tri\u1ec7u ch\u1ee9ng b\u1ec7nh tu\u1ef3 thu\u1ed9c v\u00e0o ch\u1ed7 x\u01b0\u01a1ng b\u1ecb n\u1ee9t. Chu\u0301ng ta s\u1ebd \u0111i\u1ec3m qua nh\u1eefng v\u1ecb tr\u00ed n\u1ee9t x\u01b0\u01a1ng do lo\u00e3ng x\u01b0\u01a1ng th\u01b0\u1eddng th\u1ea5y nh\u1ea5t \u1edf v\u00e0i khung h\u00ecnh k\u1ebf ti\u1ebfp nh\u00e9.  Tri\u1ec7u ch\u1ee9ng c\u1ee7a b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng: N\u1ee9t c\u1ed9t s\u1ed1ng  N\u1ee9t c\u1ed9t s\u1ed1ng (\u0111\u1ed1t s\u1ed1ng) c\u00f3 th\u1ec3 g\u00e2y \u0111au nh\u1ee9c d\u1eef d\u1ed9i, \u0111au nh\u01b0 m\u1ed9t \u201cd\u1ea3i b\u0103ng\u201d lan ra xung quanh t\u1eeb vu\u0300ng l\u01b0ng \u0111\u1ebfn hai b\u00ean h\u00f4ng ng\u01b0\u1eddi. N\u1ebfu kh\u00f4ng \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb, \u0111\u1ec3 l\u00e2u th\u00ec c\u00e1c ch\u1ed7 n\u1ee9t ti\u1ebfp n\u00e0y c\u00f3 th\u1ec3 g\u00e2y \u0111au th\u1eaft l\u01b0ng m\u00e3n t\u00ednh cu\u0303ng nh\u01b0 l\u00e0m cho b\u1ec7nh nh\u00e2n b\u1ecb lu\u0300n \u0111i ho\u1eb7c l\u00e0m cong c\u1ed9t s\u1ed1ng, ng\u01b0\u1eddi b\u1ec7nh tr\u00f4ng c\u00f3 v\u1ebb b\u1ecb gu\u0300 l\u01b0ng tr\u00ean, th\u01b0\u1eddng \u0111\u01b0\u1ee3c quy cho \u0111\u00f3 l\u00e0 \u201cb\u1ec7nh gu\u0300 l\u01b0ng.\u201d  Tri\u1ec7u ch\u1ee9ng c\u1ee7a b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng: N\u1ee9t x\u01b0\u01a1ng N\u1ee9t g\u00e3y x\u01b0\u01a1ng x\u1ea3y ra trong khi th\u1ef1c hi\u1ec7n ho\u1ea1t \u0111\u1ed9ng b\u00ecnh th\u01b0\u1eddng \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 ch\u1ea5n th\u01b0\u01a1ng n\u1ee9t x\u01b0\u01a1ng nh\u1eb9 ho\u1eb7c n\u1ee9t x\u01b0\u01a1ng nh\u1eb9. Ch\u1eb3ng h\u1ea1n nh\u01b0 m\u1ed9t s\u1ed1 b\u1ec7nh nh\u00e2n lo\u00e3ng x\u01b0\u01a1ng b\u1ecb n\u1ee9t x\u01b0\u01a1ng b\u00e0n ch\u00e2n trong khi \u0111i b\u1ed9 ho\u1eb7c b\u01b0\u1edbc xu\u1ed1ng l\u1ec1 \u0111\u01b0\u1eddng.  Tri\u1ec7u ch\u1ee9ng c\u1ee7a b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng: N\u1ee9t x\u01b0\u01a1ng h\u00f4ng  N\u1ee9t x\u01b0\u01a1ng h\u00f4ng th\u01b0\u1eddng x\u1ea3y ra khi b\u1ecb t\u00e9. \u0110\u1ed1i v\u1edbi ch\u1ee9ng lo\u00e3ng x\u01b0\u01a1ng th\u00ec n\u1ee9t x\u01b0\u01a1ng h\u00f4ng c\u00f3 th\u1ec3 l\u00e0 do c\u00e1c tai n\u1ea1n b\u00ecnh th\u01b0\u1eddng g\u00e2y n\u00ean. T\u00ecnh tr\u1ea1ng n\u1ee9t x\u01b0\u01a1ng h\u00f4ng cu\u0303ng c\u00f3 th\u1ec3 kh\u00f3 ch\u1eefa l\u00e0nh sau khi \u0111\u00e3 ph\u1eabu thu\u1eadt ch\u1ec9nh h\u00ecnh b\u1edfi ch\u1ea5t l\u01b0\u1ee3ng x\u01b0\u01a1ng b\u1ecb y\u1ebfu \u0111i nhi\u1ec1u.  H\u1eadu qu\u1ea3 c\u1ee7a b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng l\u00e0 g\u00ec? N\u1ee9t x\u01b0\u01a1ng do lo\u00e3ng x\u01b0\u01a1ng g\u00e2y ra l\u00e0m cho b\u1ec7nh nh\u00e2n \u0111au \u0111\u1edbn d\u1eef d\u1ed9i, l\u00e0m gi\u1ea3m ch\u1ea5t l\u01b0\u1ee3ng c\u1ee7a cu\u1ed9c s\u1ed1ng, g\u00e2y t\u00e0n t\u1eadt v\u00e0 kh\u00f4ng c\u00f3 kh\u1ea3 n\u0103ng l\u00e0m vi\u1ec7c n\u1eefa. C\u00f3 \u0111\u1ebfn 30% b\u1ec7nh nh\u00e2n n\u1ee9t x\u01b0\u01a1ng h\u00f4ng ph\u1ea3i \u1edf nh\u00e0 th\u01b0\u01a1ng \u0111i\u1ec1u tr\u1ecb l\u00e2u d\u00e0i. S\u1ed1 b\u1ec7nh nh\u00e2n n\u1eef t\u1eed vong sau m\u1ed9t n\u0103m b\u1ecb n\u1ee9t x\u01b0\u01a1ng h\u00f4ng l\u00e0 kho\u1ea3ng ch\u1eebng 20% m\u00e0 ch\u1ee9ng n\u1ee9t x\u01b0\u01a1ng l\u00e0 nguy\u00ean nh\u00e2n gi\u00e1n ti\u1ebfp g\u00e2y ra. Ngo\u00e0i ra, khi m\u1ed9t ng\u01b0\u1eddi \u0111\u00e3 b\u1ecb n\u1ee9t c\u1ed9t s\u1ed1ng do lo\u00e3ng x\u01b0\u01a1ng th\u00ec s\u1ebd c\u00f3 nguy c\u01a1 b\u1ecb n\u1ee9t x\u01b0\u01a1ng nh\u01b0 v\u1eady r\u1ea5t cao v\u00e0o l\u1ea7n sau trong t\u01b0\u01a1ng lai g\u1ea7n (m\u1ed9t v\u00e0i n\u0103m sau).  Y\u1ebfu t\u1ed1 n\u00e0o x\u00e1c \u0111\u1ecbnh \u0111\u01b0\u1ee3c \u0111\u1ed9 ch\u1eafc c\u1ee7a x\u01b0\u01a1ng?  Kh\u1ed1i l\u01b0\u1ee3ng x\u01b0\u01a1ng (m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng) l\u00e0 l\u01b0\u1ee3ng x\u01b0\u01a1ng c\u00f3 trong c\u1ea5u tru\u0301c x\u01b0\u01a1ng. Th\u00f4ng th\u01b0\u1eddng m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng c\u00e0ng cao th\u00ec x\u01b0\u01a1ng c\u00e0ng ch\u1eafc kh\u1ecfe. M\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng b\u1ecb \u1ea3nh h\u01b0\u1edfng r\u1ea5t l\u1edbn b\u1edfi c\u00e1c y\u1ebfu t\u1ed1 di truy\u1ec1n v\u00e0 c\u00f3 th\u1ec3 b\u1edfi m\u00f4i tr\u01b0\u1eddng v\u00e0 thu\u1ed1c men. Ch\u1eb3ng h\u1ea1n nh\u01b0 nam gi\u1edbi c\u00f3 m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng cao h\u01a1n ph\u1ee5 n\u1eef. Ng\u01b0\u1eddi M\u1ef9 g\u1ed1c Phi c\u00f3 m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng cao h\u01a1n ng\u01b0\u1eddi da tr\u1eafng ho\u1eb7c ng\u01b0\u1eddi M\u1ef9 g\u1ed1c \u00c1. M\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng th\u01b0\u1eddng \u0111\u01b0\u1ee3c t\u00edch t\u1ee5 khi c\u00f2n nh\u1ecf v\u00e0 \u0111\u1ea1t ng\u01b0\u1ee1ng cao nh\u1ea5t \u1edf \u0111\u1ed9 tu\u1ed5i 25; sau \u0111\u00f3 \u0111\u01b0\u1ee3c duy tr\u00ec trong kho\u1ea3ng ch\u1eebng 10 n\u0103m nh\u01b0 th\u1ebf. Sau 35 tu\u1ed5i, m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng th\u01b0\u1eddng s\u1ebd m\u1ea5t m\u1ed7i n\u0103m t\u1eeb 0.3% \u0111\u1ebfn 0.5% \u1edf c\u1ea3 nam l\u1eabn n\u1eef, nh\u01b0 l\u00e0 m\u1ed9t ph\u1ea7n c\u1ee7a qu\u00e1 tr\u00ecnh l\u00e3o ho\u00e1.  M\u00e3n kinh, hooc-m\u00f4n estrogen, v\u00e0 b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng Estrogen l\u00e0 hooc-m\u00f4n thi\u1ebft y\u1ebfu giu\u0301p duy tr\u00ec m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng \u1edf n\u1eef gi\u1edbi. Khi n\u1ed3ng \u0111\u1ed9 estrogen gi\u1ea3m sau m\u00e3n kinh th\u00ec m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng cu\u0303ng gi\u1ea3m nhanh ch\u00f3ng. Trong 5 \u0111\u1ebfn 10 n\u0103m \u0111\u1ea7u sau m\u00e3n kinh th\u00ec m\u1ed7i n\u0103m ph\u1ee5 n\u1eef c\u00f3 th\u1ec3 gi\u1ea3m 2%-4% m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng! \u0110i\u1ec1u n\u00e0y c\u00f3 th\u1ec3 l\u00e0m cho m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng gi\u1ea3m \u0111\u1ebfn 25%-30% trong su\u1ed1t kho\u1ea3ng th\u1eddi gian \u0111\u00f3. M\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng gi\u1ea3m nhanh sau m\u00e3n kinh l\u00e0 nguy\u00ean nh\u00e2n ch\u00ednh g\u00e2y lo\u00e3ng x\u01b0\u01a1ng \u1edf ph\u1ee5 n\u1eef.  C\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro l\u00e0m ph\u00e1t tri\u1ec3n b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng l\u00e0 g\u00ec?  * gi\u1edbi t\u00ednh n\u1eef * ch\u1ee7ng ng\u01b0\u1eddi da tr\u1eafng ho\u1eb7c ch\u00e2u \u00c1 * ng\u01b0\u1eddi c\u00f3 th\u00e2n h\u00ecnh nh\u1ecf nh\u1eafn, \u1ed1m y\u1ebfu * c\u00f3 ti\u1ec1n s\u1eed gia \u0111\u00ecnh b\u1ecb lo\u00e3ng x\u01b0\u01a1ng (ch\u1eb3ng h\u1ea1n nh\u01b0 c\u00f3 m\u1eb9 b\u1ecb n\u1ee9t x\u01b0\u01a1ng h\u00f4ng do lo\u00e3ng x\u01b0\u01a1ng s\u1ebd c\u00f3 nguy c\u01a1 n\u1ee9t x\u01b0\u01a1ng h\u00f4ng t\u0103ng g\u1ea5p \u0111\u00f4i) * c\u00f3 ti\u1ec1n s\u1eed c\u00e1 nh\u00e2n b\u1ecb n\u1ee9t x\u01b0\u01a1ng \u1edf tu\u1ed5i tr\u01b0\u1edfng th\u00e0nh  * h\u00fat thu\u1ed1c l\u00e1 * u\u1ed1ng r\u01b0\u1ee3u bia qu\u00e1 nhi\u1ec1u * thi\u1ebfu v\u1eadn \u0111\u1ed9ng * ch\u1ebf \u0111\u1ed9 dinh d\u01b0\u1ee1ng ngh\u00e8o can-xi * kh\u1ea9u ph\u1ea7n dinh d\u01b0\u1ee1ng k\u00e9m v\u00e0 s\u1ee9c kh\u1ecfe t\u1ed5ng qu\u00e1t y\u1ebfu  * k\u00e9m h\u1ea5p thu (d\u01b0\u1ee1ng ch\u1ea5t trong ru\u1ed9t kh\u00f4ng \u0111\u01b0\u1ee3c h\u1ea5p thu ho\u00e0n to\u00e0n) * n\u1ed3ng \u0111\u1ed9 hooc-m\u00f4n estrogen th\u1ea5p  * ho\u00e1 tr\u1ecb li\u1ec7u * m\u1ea5t kinh (t\u1eaft kinh) * b\u1ecb vi\u00eam m\u00e3n t\u00ednh  * b\u1ecb li\u1ec7t, b\u1ea5t \u0111\u1ed9ng, ch\u1eb3ng h\u1ea1n nh\u01b0 sau khi b\u1ecb \u0111\u1ed9t qu\u1ef5 ho\u1eb7c sau b\u1ea5t k\u1ef3 m\u1ed9t ch\u1ee9ng b\u1ec7nh n\u00e0o l\u00e0m \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn kh\u1ea3 n\u0103ng \u0111i \u0111\u1ee9ng * b\u1ecb c\u01b0\u1eddng gi\u00e1p (hooc-m\u00f4n tuy\u1ebfn gi\u00e1p qu\u00e1 cao) * b\u1ecb t\u0103ng n\u0103ng tuy\u1ebfn c\u1eadn gi\u00e1p (s\u1ea3n sinh qu\u00e1 nhi\u1ec1u hooc-m\u00f4n tuy\u1ebfn c\u1eadn gi\u00e1p l\u00e0m cho x\u01b0\u01a1ng b\u1ecb m\u1ea5t qu\u00e1 nhi\u1ec1u can-xi) * thi\u1ebfu vitamin D (vitamin D giu\u0301p cho c\u01a1 th\u1ec3 h\u1ea5p th\u1ee5 can-xi) * m\u1ed9t s\u1ed1 thu\u1ed1c n\u00e0o \u0111\u00f3 cu\u0303ng c\u00f3 th\u1ec3 g\u00e2y lo\u00e3ng x\u01b0\u01a1ng ch\u1eb3ng h\u1ea1n nh\u01b0 s\u1eed d\u1ee5ng thu\u1ed1c h\u00ea-pa-rin (ch\u1ea5t/ thu\u1ed1c l\u00e0m lo\u00e3ng m\u00e1u) trong th\u1eddi gian d\u00e0i, thu\u1ed1c ch\u1ed1ng \u0111\u1ed9ng kinh phenytoin (Dilantin) v\u00e0 thu\u1ed1c an th\u1ea7n/ thu\u1ed1c ng\u1ee7, v\u00e0 s\u1eed d\u1ee5ng corticosteroid d\u1ea1ng u\u1ed1ng (ho\u00f3c-m\u00f4n xt\u00ea-r\u00f4-\u00edt do v\u1ecf th\u01b0\u1ee3ng th\u1eadn t\u1ed5ng h\u1ee3p) l\u00e2u d\u00e0i (ch\u1eb3ng h\u1ea1n nh\u01b0 thu\u1ed1c kh\u00e1ng vi\u00eam prednisone) B\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng \u0111\u01b0\u1ee3c ch\u1ea9n \u0111o\u00e1n nh\u01b0 th\u1ebf n\u00e0o?  Ph\u01b0\u01a1ng ph\u00e1p ch\u1ee5p X-quang \u0111\u1ecbnh k\u1ef3 c\u00f3 th\u1ec3 cho bi\u1ebft b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng \u2013 x\u01b0\u01a1ng tr\u00f4ng c\u00f3 v\u1ebb m\u1ecfng v\u00e0 nh\u1eb9 h\u01a1n nhi\u1ec1u so v\u1edbi x\u01b0\u01a1ng b\u00ecnh th\u01b0\u1eddng. \u0110\u00e1ng ti\u1ebfc l\u00e0 khi tia X c\u00f3 th\u1ec3 ph\u00e1t hi\u1ec7n ra lo\u00e3ng x\u01b0\u01a1ng th\u00ec \u0111\u00e3 c\u00f3 \u00edt nh\u1ea5t 30% x\u01b0\u01a1ng \u0111\u00e3 b\u1ecb m\u1ea5t. Ngo\u00e0i ra, th\u1ee7 thu\u1eadt n\u00e0y cu\u0303ng kh\u00f4ng cho bi\u1ebft ch\u00ednh x\u00e1c m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng. Vi\u1ec7c thay \u0111\u1ed5i \u0111\u1ed9 ch\u1ee5p phim X-quang cu\u0303ng th\u01b0\u1eddng l\u00e0m \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn v\u1ebb ngo\u00e0i c\u1ee7a x\u01b0\u01a1ng tr\u00ean tia X. T\u1ed5 ch\u1ee9c Lo\u00e3ng x\u01b0\u01a1ng Qu\u1ed1c gia, Hi\u1ec7p h\u1ed9i Y h\u1ecdc Hoa K\u1ef3, v\u00e0 c\u00e1c t\u1ed5 ch\u1ee9c y t\u1ebf l\u1edbn kh\u00e1c \u0111ang khuy\u1ebfn c\u00e1o ph\u01b0\u01a1ng ph\u00e1p \u0111o h\u1ea5p th\u1ee5 n\u0103ng l\u01b0\u1ee3ng tia X k\u00e9p (DEXA ho\u1eb7c DXA) \u0111\u1ec3 ch\u1ea9n \u0111o\u00e1n lo\u00e3ng x\u01b0\u01a1ng. X\u00e9t nghi\u1ec7m \u0111o m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng h\u00f4ng v\u00e0 c\u1ed9t s\u1ed1ng ch\u1ec9 m\u1ea5t t\u1eeb 5 \u0111\u1ebfn 15 phu\u0301t, s\u1eed d\u1ee5ng b\u1ee9c x\u1ea1 r\u1ea5t nh\u1ecf (ch\u01b0a \u0111\u1ea7y 1/10 \u0111\u1ebfn 1/100 l\u01b0\u1ee3ng b\u1ee9c x\u1ea1 du\u0300ng \u0111\u1ec3 ch\u1ee5p X- quang ng\u1ef1c chu\u1ea9n), v\u00e0 bi\u1ec7n ph\u00e1p n\u00e0y kh\u00e1 ch\u00ednh x\u00e1c.  \u0110\u1ed1i t\u01b0\u1ee3ng n\u00e0o n\u00ean x\u00e9t nghi\u1ec7m m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng?  T\u1ed5 ch\u1ee9c Lo\u00e3ng x\u01b0\u01a1ng Qu\u1ed1c gia ch\u1ec9 ra nguy\u00ean t\u1eafc m\u1ed9t s\u1ed1 nh\u00f3m ng\u01b0\u1eddi n\u00ean th\u1ef1c hi\u1ec7n x\u00e9t nghi\u1ec7m DXA:  * ph\u1ee5 n\u1eef sau m\u00e3n kinh d\u01b0\u1edbi 65 tu\u1ed5i, c\u00f3 nguy c\u01a1 b\u1ecb lo\u00e3ng x\u01b0\u01a1ng;  * ph\u1ee5 n\u1eef tu\u1ed5i t\u1eeb 65 tr\u1edf l\u00ean; * ph\u1ee5 n\u1eef sau m\u00e3n kinh b\u1ecb n\u1ee9t x\u01b0\u01a1ng, m\u1eb7c du\u0300 \u0111\u00e2y kh\u00f4ng ph\u1ea3i l\u00e0 \u0111i\u1ec1u b\u1eaft bu\u1ed9c b\u1edfi ng\u01b0\u1eddi ta cu\u0303ng c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u \u0111i\u1ec1u tr\u1ecb m\u00e0 kh\u00f4ng k\u1ec3 \u0111\u1ebfn m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng;  * ph\u1ee5 n\u1eef b\u1ecb m\u1ed9t trong c\u00e1c b\u1ec7nh li\u00ean quan \u0111\u1ebfn lo\u00e3ng x\u01b0\u01a1ng  K\u1ebft qu\u1ea3 m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng \u0111\u01b0\u1ee3c \u0111o nh\u01b0 th\u1ebf n\u00e0o?  Sau khi qu\u00e9t/ch\u1ee5p DXA xong, m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng c\u1ee7a b\u1ec7nh nh\u00e2n \u0111\u01b0\u1ee3c \u0111em \u0111\u1ed1i chi\u1ebfu v\u1edbi m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng \u1edf ng\u01b0\u1ee1ng cao nh\u1ea5t b\u00ecnh th\u01b0\u1eddng c\u1ee7a thanh ni\u00ean cu\u0300ng ch\u1ee7ng t\u1ed9c v\u00e0 gi\u1edbi t\u00ednh. \u0110\u00e2y g\u1ecdi l\u00e0 ch\u1ec9 s\u1ed1 T (T score) \u2013 cho bi\u1ebft m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng trong c\u00e1c kho\u1ea3ng sai l\u1ec7ch chu\u1ea9n (SD).  * N\u1ebfu m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng T score l\u00e0 -2.5 SD tr\u1edf xu\u1ed1ng: lo\u00e3ng x\u01b0\u01a1ng. * Ti\u1ec1n lo\u00e3ng x\u01b0\u01a1ng (gi\u1eefa tr\u1ea1ng th\u00e1i b\u00ecnh th\u01b0\u1eddng v\u00e0 lo\u00e3ng x\u01b0\u01a1ng) \u0111\u01b0\u1ee3c x\u00e1c \u0111\u1ecbnh khi m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng T score dao \u0111\u1ed9ng gi\u1eefa 1 v\u00e0 2.5 SD \u0111\u1ed1i v\u1edbi ph\u1ee5 n\u1eef tu\u1ed5i t\u1eeb 65 tr\u1edf l\u00ean;  \u0110i\u1ec1u tr\u1ecb v\u00e0 ph\u00f2ng tr\u00e1nh b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng nh\u01b0 th\u1ebf n\u00e0o?  M\u1ee5c ti\u00eau c\u1ee7a vi\u1ec7c \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng l\u00e0 ph\u00f2ng tr\u00e1nh n\u1ee9t x\u01b0\u01a1ng b\u1eb1ng c\u00e1ch ng\u0103n kh\u00f4ng cho m\u1ea5t x\u01b0\u01a1ng v\u00e0 l\u00e0m t\u0103ng m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng v\u00e0 l\u00e0m cho x\u01b0\u01a1ng ch\u1eafc kh\u1ecfe h\u01a1n. M\u1eb7c du\u0300 bi\u1ec7n ph\u00e1p ph\u00e1t hi\u1ec7n s\u1edbm v\u00e0 \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng k\u1ecbp th\u1eddi c\u00f3 th\u1ec3 l\u00e0m gi\u1ea3m \u0111\u00e1ng k\u1ec3 nguy c\u01a1 n\u1ee9t x\u01b0\u01a1ng v\u1ec1 sau, kh\u00f4ng c\u00f3 ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng n\u00e0o ch\u1eefa l\u00e0nh ch\u1ee9ng b\u1ec7nh n\u00e0y ho\u00e0n to\u00e0n. N\u00f3i m\u1ed9t c\u00e1ch kh\u00e1c l\u00e0 kh\u00f3 c\u00f3 th\u1ec3 l\u00e0m x\u01b0\u01a1ng b\u1ecb y\u1ebfu do lo\u00e3ng x\u01b0\u01a1ng g\u00e2y ra tr\u1edf l\u1ea1i c\u1ee9ng c\u00e1p ho\u00e0n to\u00e0n \u0111\u01b0\u1ee3c. Do \u0111\u00f3, bi\u1ec7n ph\u00e1p ph\u00f2ng tr\u00e1nh lo\u00e3ng x\u01b0\u01a1ng \u0111\u01b0\u1ee3c coi l\u00e0 quan tr\u1ecdng nh\u01b0 vi\u1ec7c \u0111i\u1ec1u tr\u1ecb v\u1eady. Chu\u0301ng ta s\u1ebd quan s\u00e1t m\u1ed9t s\u1ed1 c\u00e1ch ph\u00f2ng tr\u00e1nh v\u00e0 \u0111i\u1ec1u tr\u1ecb \u1edf nh\u1eefng khung h\u00ecnh b\u00ean d\u01b0\u1edbi nh\u00e9.  Ph\u00f2ng tr\u00e1nh v\u00e0 \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng b\u1eb1ng b\u00e0i t\u1eadp  Th\u1ec3 d\u1ee5c r\u1ea5t c\u00f3 l\u1ee3i cho s\u1ee9c kh\u1ecfe. Tuy nhi\u00ean, th\u1ec3 d\u1ee5c kh\u00f4ng l\u00e0m t\u0103ng m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng \u0111\u00e1ng k\u1ec3 \u0111\u01b0\u1ee3c. L\u1ee3i \u00edch c\u1ee7a th\u1ec3 d\u1ee5c \u0111\u1ed1i v\u1edbi b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng ch\u1ee7 y\u1ebfu l\u00e0 l\u00e0m gi\u1ea3m nguy c\u01a1 t\u00e9 ng\u00e3, c\u00f3 l\u1ebd b\u1edfi giu\u0301p c\u01a1 th\u1ec3 th\u0103ng b\u1eb1ng h\u01a1n v\u00e0/ho\u1eb7c l\u00e0m n\u00e2ng cao s\u1ee9c m\u1ea1nh c\u01a1 b\u1eafp. Nghi\u00ean c\u1ee9u cu\u0303ng ch\u01b0a x\u00e1c \u0111\u1ecbnh ch\u00ednh x\u00e1c l\u00e0 lo\u1ea1i b\u00e0i t\u1eadp n\u00e0o ho\u1eb7c th\u1eddi gian t\u1eadp l\u00e0 bao nhi\u00eau l\u00e0 t\u1ed1t nh\u1ea5t cho b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng. Tuy v\u1eady, h\u1ea7u h\u1ebft c\u00e1c b\u00e1c s\u0129 khuy\u1ebfn c\u00e1o n\u00ean t\u1eadp c\u1eed t\u1ea1, \u0111i b\u1ed9, t\u1ed1t nh\u1ea5t l\u00e0 n\u00ean t\u1eadp h\u1eb1ng ng\u00e0y.  C\u1ea3nh gi\u00e1c v\u1edbi b\u00e0i t\u1eadp th\u1ec3 d\u1ee5c \u0110i\u1ec1u quan tr\u1ecdng l\u00e0 ph\u1ea3i tr\u00e1nh c\u00e1c b\u00e0i t\u1eadp c\u00f3 th\u1ec3 g\u00e2y ch\u1ea5n th\u01b0\u01a1ng cho nh\u1eefng x\u01b0\u01a1ng \u0111\u00e3 b\u1ecb y\u1ebfu s\u1eb5n. \u0110\u1ed1i v\u1edbi b\u1ec7nh nh\u00e2n tr\u00ean 40 tu\u1ed5i v\u00e0 ng\u01b0\u1eddi b\u1ecb b\u1ec7nh tim, b\u00e9o ph\u00ec, ti\u1ec3u \u0111\u01b0\u1eddng, v\u00e0 huy\u1ebft \u00e1p cao, th\u00ec b\u00e0i t\u1eadp c\u1ee7a h\u1ecd n\u00ean \u0111\u01b0\u1ee3c b\u00e1c s\u0129 quy \u0111\u1ecbnh v\u00e0 gi\u00e1m s\u00e1t. Cu\u1ed1i cu\u0300ng l\u00e0 m\u1ee9c \u0111\u1ed9 th\u1ec3 d\u1ee5c qu\u00e1 nhi\u1ec1u (ch\u1eb3ng h\u1ea1n nh\u01b0 cu\u1ed9c ch\u1ea1y \u0111ua ma-ra-t\u00f4ng) c\u00f3 th\u1ec3 l\u00e0 kh\u00f4ng kh\u1ecfe cho x\u01b0\u01a1ng. Ch\u1ea1y \u0111ua ma-ra-t\u00f4ng \u1edf n\u1eef thanh ni\u00ean d\u1eabn \u0111\u1ebfn gi\u1ea3m c\u00e2n v\u00e0 t\u1eafc kinh c\u00f3 th\u1ec3 th\u1ef1c s\u1ef1 g\u00e2y lo\u00e3ng x\u01b0\u01a1ng. Ph\u00f2ng tr\u00e1nh v\u00e0 \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng: B\u1ecf thu\u1ed1c l\u00e1 v\u00e0 h\u1ea1n ch\u1ebf r\u01b0\u1ee3u bia  Hu\u0301t m\u1ed9t g\u00f3i thu\u1ed1c m\u1ed9t ng\u00e0y su\u1ed1t th\u1eddi thanh ni\u00ean c\u00f3 th\u1ec3 t\u1ef1 l\u00e0m m\u1ea5t 5%-10% kh\u1ed1i l\u01b0\u1ee3ng x\u01b0\u01a1ng. Hu\u0301t thu\u1ed1c l\u00e1 l\u00e0m gi\u1ea3m n\u1ed3ng \u0111\u1ed9 estrogen v\u00e0 c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn t\u00ecnh tr\u1ea1ng m\u1ea5t x\u01b0\u01a1ng \u1edf ph\u1ee5 n\u1eef tr\u01b0\u1edbc m\u00e3n kinh. Vi\u1ec7c hu\u0301t thu\u1ed1c l\u00e1 cu\u0303ng c\u00f3 th\u1ec3 l\u00e0m m\u00e3n kinh s\u1edbm h\u01a1n.  Th\u00f4ng tin v\u1ec1 \u1ea3nh h\u01b0\u1edfng c\u1ee7a vi\u1ec7c th\u01b0\u1eddng xuy\u00ean u\u1ed1ng r\u01b0\u1ee3u bia v\u00e0 c\u00e0-ph\u00ea-in \u0111\u1ed1i v\u1edbi ch\u1ee9ng lo\u00e3ng x\u01b0\u01a1ng kh\u00f4ng r\u00f5 nh\u01b0 \u1ea3nh h\u01b0\u1edfng c\u1ee7a thu\u1ed1c l\u00e1 v\u00e0 b\u00e0i t\u1eadp th\u1ec3 d\u1ee5c. Th\u1ef1c ra, cu\u1ed9c nghi\u00ean c\u1ee9u xem r\u01b0\u1ee3u bia v\u00e0 c\u00e0-ph\u00ea-in l\u00e0 c\u00e1c y\u1ebfu t\u1ed1 nguy hi\u1ec3m \u0111\u1ed1i v\u1edbi b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng cho th\u1ea5y nhi\u1ec1u k\u1ebft qu\u1ea3 r\u1ea5t kh\u00e1c bi\u1ec7t nhau v\u00e0 ng\u01b0\u1eddi ta v\u1eabn c\u00f2n \u0111ang tranh c\u00e3i v\u1ec1 v\u1ea5n \u0111\u1ec1 n\u00e0y. T\u1ea5t nhi\u00ean l\u00e0, nh\u1eefng \u1ea3nh h\u01b0\u1edfng n\u00e0y kh\u00f4ng m\u1ea1nh nh\u01b0 nh\u1eefng y\u1ebfu t\u1ed1 kh\u00e1c. M\u1eb7c du\u0300 v\u1eady, vi\u1ec7c ti\u1ebft ch\u1ebf r\u01b0\u1ee3u bia v\u00e0 c\u00e0-ph\u00ea-in l\u00e0 v\u1ea5n \u0111\u1ec1 th\u1eadn tr\u1ecdng.  Ph\u00f2ng tr\u00e1nh v\u00e0 \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng b\u1eb1ng c\u00e1ch b\u1ed5 sung can-xi Vi\u1ec7c x\u00e2y d\u1ef1ng x\u01b0\u01a1ng ch\u1eafc kh\u1ecfe \u0111\u00f2i h\u1ecfi ph\u1ea3i b\u1ed5 sung \u0111\u1ea7y \u0111\u1ee7 can-xi trong ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng v\u00e0 luy\u1ec7n t\u1eadp th\u1ec3 d\u1ee5c b\u1eaft \u0111\u1ea7u ngay t\u1eeb nh\u1ecf v\u00e0 t\u1eeb th\u1eddi tr\u1ebb \u0111\u1ed1i v\u1edbi c\u1ea3 nam l\u1eabn n\u1eef. \u0110i\u1ec1u quan tr\u1ecdng l\u00e0, m\u1ed9t khi b\u1ec7nh nh\u00e2n \u0111\u00e3 b\u1ecb lo\u00e3ng x\u01b0\u01a1ng th\u00ec vi\u1ec7c b\u1ed5 sung can-xi li\u1ec1u cao trong kh\u1ea9u ph\u1ea7n dinh d\u01b0\u1ee1ng ho\u1eb7c ch\u1ec9 b\u1ed5 sung can-xi kh\u00f4ng \u0111\u1ee7 \u0111\u1ec3 c\u00f3 th\u1ec3 ch\u1eefa l\u00e0nh \u0111\u01b0\u1ee3c b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng v\u00e0 kh\u00f4ng n\u00ean xem \u0111\u00f3 l\u00e0 thu\u1ed1c thay th\u1ebf ho\u1eb7c th\u1ebf cho c\u00e1c lo\u1ea1i thu\u1ed1c tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng theo toa hi\u1ec7u nghi\u1ec7m h\u01a1n. Trong m\u1ed9t v\u00e0i n\u0103m \u0111\u1ea7u sau m\u00e3n kinh, x\u01b0\u01a1ng c\u00f3 th\u1ec3 b\u1ecb m\u1ea5t nhanh ch\u00f3ng cho du\u0300 l\u00e0 b\u1ec7nh nh\u00e2n \u0111\u01b0\u1ee3c b\u1ed5 sung can-xi \u0111i n\u1eefa.  Ti\u1ebfc l\u00e0, nhi\u1ec1u cu\u1ed9c kh\u1ea3o s\u00e1t \u1edf Hoa K\u1ef3 cho th\u1ea5y ph\u1ee5 n\u1eef th\u01b0\u1eddng h\u1ea5p thu ch\u01b0a \u0111\u1ea7y 500 milligram can-xi trong ch\u1ebf \u0111\u1ed9 dinh d\u01b0\u1ee1ng m\u1ed7i ng\u00e0y, th\u1ea5p h\u01a1n l\u01b0\u1ee3ng can-xi \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb. Ngo\u00e0i ra can-xi c\u00f2n c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c b\u1ed5 sung th\u00eam b\u1eb1ng c\u00e1ch u\u1ed1ng nhi\u1ec1u s\u1eefa v\u00e0 \u0103n th\u00eam nhi\u1ec1u s\u1eefa chua ho\u1eb7c ph\u00f4 mai l\u00e0m t\u1eeb s\u1eefa \u0111\u00e3 g\u1ea1n kem ho\u1eb7c b\u1eb1ng c\u00e1ch b\u1ed5 sung th\u00eam vi\u00ean can-xi cu\u0303ng nh\u01b0 th\u1ef1c ph\u1ea9m b\u1ed5 sung ch\u1ea5t v\u00f4i, ch\u1eb3ng h\u1ea1n nh\u01b0 n\u01b0\u1edbc cam \u00e9p.  Ph\u00f2ng tr\u00e1nh v\u00e0 \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng b\u1eb1ng th\u1ee9c \u0103n b\u1ed5 sung ch\u1ea5t v\u00f4i  Ngo\u00e0i c\u00e1c s\u1ea3n ph\u1ea9m l\u00e0m t\u1eeb s\u1eefa th\u00ec kh\u1ea9u ph\u1ea7n dinh d\u01b0\u1ee1ng c\u1ee7a ng\u01b0\u1eddi M\u1ef9 trung b\u00ecnh ch\u1ee9a kho\u1ea3ng 250 mg can-xi. Nh\u01b0 \u0111\u00e3 \u0111\u1ec1 c\u1eadp \u0111\u1ebfn \u1edf khung h\u00ecnh tr\u01b0\u1edbc, d\u01b0\u1edbi \u0111\u00e2y l\u00e0 m\u1ed9t s\u1ed1 v\u00ed d\u1ee5 v\u1ec1 th\u1ef1c ph\u1ea9m b\u1ed5 sung ch\u1ea5t v\u00f4i v\u00e0 l\u01b0\u1ee3ng can-xi h\u1ea5p thu t\u01b0\u01a1ng \u1ee9ng.  Ph\u00f2ng tr\u00e1nh v\u00e0 \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng b\u1eb1ng vitamin D  Vi\u1ec7c h\u1ea5p th\u1ee5 \u0111\u1ea7y \u0111\u1ee7 can-xi v\u00e0 d\u1ef1 tr\u1eef \u0111\u1ee7 vitamin D trong c\u01a1 th\u1ec3 l\u00e0 n\u1ec1n t\u1ea3ng quan tr\u1ecdng \u0111\u1ec3 duy tr\u00ec m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng v\u00e0 gi\u1eef cho x\u01b0\u01a1ng ch\u1eafc kh\u1ecfe. Ti\u1ebfc l\u00e0 ch\u1ee9ng thi\u1ebfu vitamin D r\u1ea5t th\u01b0\u1eddng th\u1ea5y \u1edf M\u1ef9. Vitamin D c\u1ea7n thi\u1ebft \u1edf nhi\u1ec1u l\u0129nh v\u1ef1c kh\u00e1c nhau:  * vitamin D giu\u0301p h\u1ea5p thu can-xi t\u1eeb ru\u1ed9t;  * thi\u1ebfu vitamin D l\u00e0m cho x\u01b0\u01a1ng b\u1ecb c\u1ea1n h\u1ebft can-xi (nhuy\u1ec5n x\u01b0\u01a1ng), l\u00e0m cho x\u01b0\u01a1ng tr\u1edf n\u00ean y\u1ebfu h\u01a1n v\u00e0 l\u00e0m t\u0103ng nguy c\u01a1 n\u1ee9t g\u00e3y, v\u00e0  * vitamin D, v\u00e0 can-xi \u0111\u1ea7y \u0111\u1ee7 (1,200 mg can-xi c\u01a1 b\u1ea3n), trong m\u1ed9t s\u1ed1 nghi\u00ean c\u1ee9u \u0111\u00e3 cho th\u1ea5y k\u1ebft qu\u1ea3 l\u00e0m t\u0103ng m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng v\u00e0 giu\u0301p cho ng\u01b0\u1eddi gi\u00e0 sau m\u00e3n kinh gi\u1ea3m n\u1ee9t x\u01b0\u01a1ng nh\u01b0ng kh\u00f4ng c\u00f3 t\u00e1c d\u1ee5ng \u0111\u1ed1i v\u1edbi ph\u1ee5 n\u1eef ti\u1ec1n m\u00e3n kinh ho\u1eb7c g\u1ea7n m\u00e3n kinh.  U\u0309y ban Th\u1ef1c ph\u1ea9m v\u00e0 Dinh d\u01b0\u1ee1ng thu\u1ed9c Vi\u1ec7n Y h\u1ecdc \u0111\u00e3 khuy\u1ebfn ngh\u1ecb n\u00ean b\u1ed5 sung \u0111\u1ea7y \u0111\u1ee7 vitamin D nh\u01b0 sau: * 200 IU/ ng\u00e0y \u0111\u1ed1i v\u1edbi c\u1ea3 nam l\u1eabn n\u1eef t\u1eeb 19 \u0111\u1ebfn 50 tu\u1ed5i  * 400 IU/ ng\u00e0y \u0111\u1ed1i v\u1edbi c\u1ea3 nam l\u1eabn n\u1eef t\u1eeb 51 \u0111\u1ebfn 70 tu\u1ed5i; v\u00e0  * IU m\u1ed7i ng\u00e0y cho c\u1ea3 nam l\u1eabn n\u1eef t\u1eeb 71 tu\u1ed5i tr\u1edf l\u00ean.  C\u00e1c ngu\u1ed3n cung c\u1ea5p vitamin D d\u1ed3i d\u00e0o g\u1ed3m \u00e1nh n\u1eafng t\u1ef1 nhi\u00ean, s\u1eefa b\u1ed5 sung vitamin D, ph\u00f4 mai, b\u01a1/b\u01a1 th\u1ef1c v\u1eadt, ngu\u0303 c\u1ed1c v\u00e0 c\u00e1.  Ph\u00f2ng tr\u00e1nh v\u00e0 \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng b\u1eb1ng li\u1ec7u ph\u00e1p hooc-m\u00f4n m\u00e3n kinh  Li\u1ec7u ph\u00e1p hooc-m\u00f4n m\u00e3n kinh (tr\u01b0\u1edbc \u0111\u00e2y g\u1ecdi l\u00e0 li\u1ec7u ph\u00e1p thay th\u1ebf hooc-m\u00f4n ho\u1eb7c HRT) \u0111\u00e3 c\u00f3 t\u00e1c d\u1ee5ng ph\u00f2ng tr\u00e1nh m\u1ea5t x\u01b0\u01a1ng, t\u0103ng m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng, v\u00e0 ng\u0103n ng\u1eeba \u0111\u01b0\u1ee3c ch\u1ee9ng n\u1ee9t x\u01b0\u01a1ng. Hooc-m\u00f4n estrogen c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng d\u1ea1ng u\u1ed1ng (Premarin, Estrace, Estratest, v\u00e0 nhi\u1ec1u lo\u1ea1i kh\u00e1c) ho\u1eb7c d\u00e1n tr\u00ean da (Estraderm, Vivelle, v\u00e0 nhi\u1ec1u lo\u1ea1i kh\u00e1c). Estrogen cu\u0303ng c\u00f3 th\u1ec3 k\u1ebft h\u1ee3p v\u1edbi progesterone \u1edf d\u1ea1ng vi\u00ean v\u00e0 mi\u1ebfng d\u00e1n. Progesterone th\u01b0\u1eddng \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng v\u1edbi estrogen \u0111\u1ec3 ng\u0103n ng\u1eeba ung th\u01b0 t\u1eed cung c\u00f3 th\u1ec3 do s\u1eed d\u1ee5ng estrogen ri\u00eang l\u1ebb. Do li\u1ec7u ph\u00e1p hooc-m\u00f4n m\u00e3n kinh g\u00e2y \u1ea3nh h\u01b0\u1edfng x\u1ea5u, ch\u1eb3ng h\u1ea1n nh\u01b0 l\u00e0m t\u0103ng nguy c\u01a1 \u0111au tim, \u0111\u1ed9t qu\u1ef5, t\u1eafc ngh\u1ebdn t\u0129nh m\u1ea1ch, v\u00e0 ung th\u01b0 vu\u0301, n\u00ean li\u1ec7u ph\u00e1p n\u00e0y kh\u00f4ng c\u00f2n \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng trong th\u1eddi gian d\u00e0i n\u1eefa m\u00e0 ch\u1ec9 s\u1eed d\u1ee5ng ng\u1eafn h\u1ea1n nh\u1eb1m l\u00e0m gi\u1ea3m c\u01a1n tr\u00e0o huy\u1ebft m\u00e3n kinh (k\u00e8m theo m\u1ea5t th\u0103ng b\u1eb1ng hooc-m\u00f4n lu\u0301c m\u00e3n kinh). Ph\u1ee5 n\u1eef n\u00ean th\u1ea3o lu\u1eadn ri\u00eang v\u1edbi b\u00e1c s\u0129 v\u1ec1 li\u1ec7u ph\u00e1p thay th\u1ebf hooc-m\u00f4n estrogen.  Ph\u00f2ng tr\u00e1nh v\u00e0 \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng b\u1eb1ng thu\u1ed1c Hi\u1ec7n nay, nhi\u1ec1u lo\u1ea1i thu\u1ed1c tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng c\u00f4ng hi\u1ec7u nh\u1ea5t \u0111\u00e3 \u0111\u01b0\u1ee3c C\u01a1 quan gi\u00e1m s\u00e1t an to\u00e0n th\u1ef1c ph\u1ea9m v\u00e0 d\u01b0\u1ee3c ph\u1ea9m FDA ph\u00ea duy\u1ec7t l\u00e0 thu\u1ed1c ch\u1ed1ng hu\u1ef7 x\u01b0\u01a1ng, ph\u00f2ng tr\u00e1nh g\u00e3y x\u01b0\u01a1ng. Nhi\u1ec1u thu\u1ed1c ch\u1ed1ng hu\u1ef7 x\u01b0\u01a1ng ng\u0103n kh\u00f4ng cho m\u1ea5t x\u01b0\u01a1ng (ph\u00e2n hu\u1ef7 x\u01b0\u01a1ng), do \u0111\u00f3 d\u1eabn \u0111\u1ebfn vi\u1ec7c t\u00e1i x\u00e2y d\u1ef1ng x\u01b0\u01a1ng v\u00e0 l\u00e0m t\u0103ng m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng. Li\u1ec7u ph\u00e1p hooc-m\u00f4n estrogen m\u00e3n kinh l\u00e0 m\u1ed9t tr\u01b0\u1eddng h\u1ee3p v\u00ed d\u1ee5 cho thu\u1ed1c ch\u1ed1ng hu\u1ef7 x\u01b0\u01a1ng. Nhi\u1ec1u lo\u1ea1i thu\u1ed1c kh\u00e1c g\u1ed3m alendronate (Fosamax), risedronate (Actonel), raloxifene (Evista), ibandronate (Boniva), calcitonin (Calcimar), v\u00e0 zoledronate (Reclast). Ph\u00f2ng tr\u00e1nh n\u1ee9t x\u01b0\u01a1ng h\u00f4ng  T\u1ed5 ch\u1ee9c FDA \u0111\u00e3 cho ph\u00e9p du\u0300ng qu\u1ea7n \u00e1o b\u1ea3o v\u1ec7 h\u00f4ng \u0111\u1ec3 ng\u0103n ng\u1eeba g\u00e3y x\u01b0\u01a1ng h\u00f4ng \u1edf ng\u01b0\u1eddi gi\u00e0 b\u1ecb lo\u00e3ng x\u01b0\u01a1ng d\u1ec5 t\u00e9 ng\u00e3. T\u00ean th\u01b0\u01a1ng hi\u1ec7u l\u00e0 Hipsaver and Safehip. Ph\u01b0\u01a1ng ph\u00e1p n\u00e0y c\u00f3 th\u1ec3 c\u00f3 \u00edch cho nh\u1eefng b\u1ec7nh nh\u00e2n s\u1ed1ng \u1edf m\u00f4i tr\u01b0\u1eddng vi\u1ec7n d\u01b0\u1ee1ng l\u00e3o, m\u1eb7c du\u0300 m\u1ee9c \u0111\u1ed9 ph\u00f2ng tr\u00e1nh n\u1ee9t x\u01b0\u01a1ng h\u00f4ng th\u1ef1c s\u1ef1 nh\u1edd s\u1eed d\u1ee5ng d\u1ee5ng c\u1ee5 b\u1ea3o v\u1ec7 h\u00f4ng l\u00e0 \u0111i\u1ec1u m\u00e0 ng\u01b0\u1eddi ta hi\u1ec7n v\u1eabn c\u00f2n \u0111ang tranh c\u00e3i.  Nh\u00ecn s\u01a1 l\u01b0\u1ee3c v\u1ec1 b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng  * Lo\u00e3ng x\u01b0\u01a1ng l\u00e0 b\u1ec7nh x\u01b0\u01a1ng d\u1ec5 g\u00e3y n\u1ee9t do x\u01b0\u01a1ng b\u1ecb m\u1ecfng \u0111i.  * B\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng l\u00e0m cho x\u01b0\u01a1ng y\u1ebfu v\u00e0 l\u00e0m t\u0103ng nguy c\u01a1 n\u1ee9t x\u01b0\u01a1ng.  * Kh\u1ed1i l\u01b0\u1ee3ng x\u01b0\u01a1ng (m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng) gi\u1ea3m sau 35 tu\u1ed5i v\u00e0 gi\u1ea3m nhanh h\u01a1n \u1edf ph\u1ee5 n\u1eef sau m\u00e3n kinh.  * C\u00e1c y\u1ebfu t\u1ed1 nguy hi\u1ec3m ch\u00ednh y\u1ebfu c\u1ee7a b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng g\u1ed3m y\u1ebfu t\u1ed1 di truy\u1ec1n, thi\u1ebfu v\u1eadn \u0111\u1ed9ng, thi\u1ebfu can-xi v\u00e0 thi\u1ebfu vitamin D, c\u00f3 ti\u1ec1n s\u1eed c\u00e1 nh\u00e2n b\u1ecb n\u1ee9t x\u01b0\u01a1ng \u1edf tu\u1ed5i tr\u01b0\u1edfng th\u00e0nh, b\u1ecb vi\u00eam kh\u1edbp kinh ni\u00ean, h\u00fat thu\u1ed1c, u\u1ed1ng r\u01b0\u1ee3u qu\u00e1 nhi\u1ec1u, nh\u1eb9 c\u00e2n, v\u00e0 c\u00f3 ti\u1ec1n s\u1eed gia \u0111\u00ecnh b\u1ecb lo\u00e3ng x\u01b0\u01a1ng. * B\u1ec7nh nh\u00e2n b\u1ecb lo\u00e3ng x\u01b0\u01a1ng kh\u00f4ng c\u00f3 tri\u1ec7u ch\u1ee9ng g\u00ec cho \u0111\u1ebfn khi c\u00f3 bi\u1ec3u hi\u1ec7n n\u1ee9t x\u01b0\u01a1ng.  * C\u00f3 th\u1ec3 s\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p ch\u1ee5p X-quang \u0111\u1ec3 ch\u1ea9n \u0111o\u00e1n b\u1ec7nh lo\u00e3ng x\u01b0\u01a1ng v\u00e0 l\u00e0m nhi\u1ec1u x\u00e9t nghi\u1ec7m kh\u00e1c \u0111\u1ec3 x\u00e1c \u0111\u1ecbnh l\u1ea1i nh\u1eb1m \u0111o m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng.  * C\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb lo\u00e3ng x\u01b0\u01a1ng, ngo\u00e0i nh\u1eefng lo\u1ea1i thu\u1ed1c ch\u1eefa lo\u00e3ng x\u01b0\u01a1ng theo toa, nh\u01b0 b\u1ecf thu\u1ed1c l\u00e1 v\u00e0 r\u01b0\u1ee3u bia, v\u00e0 \u0111\u1ea3m b\u1ea3o n\u00ean t\u1eadp th\u1ec3 d\u1ee5c, b\u1ed5 sung can-xi v\u00e0 vitamin D \u0111\u1ea7y \u0111\u1ee7."
        },
        {
            "en": "Your child\u2019s immunization        At birth, infants have protection against certain diseases because antibodies have passed through the placenta from the mother to the unborn child. After birth, breastfed babies get the continued benefits of additional antibodies in breast milk. But in both cases, the protection is temporary. Immunization (vaccination) is a way of creating immunity to certain diseases by using small amounts of a killed or weakened microorganism that causes the particular disease. Microorganisms can be viruses, such as the measles virus, or they can be bacteria, such as pneumococcus. Vaccines stimulate the immune system to react as if there were a real infection \u2014 it fends off the \"infection\" and remembers the organism so that it can fight it quickly should it enter the body later. Some parents may hesitate to have their kids vaccinated because they're worried that the children will have serious reactions or may get the illness the vaccine is supposed to prevent. Because the components of vaccines are weakened or killed \u2014 and in some cases, only parts of the microorganism are used \u2014 they're unlikely to cause any serious illness. Some vaccines may cause mild reactions, such as soreness where the shot was given or fever, but serious reactions are rare. The risks of vaccinations are small compared with the health risks associated with the diseases they're intended to prevent. The following vaccinations and schedules are recommended by the American Academy of Pediatrics (AAP). Please note that some variations are acceptable and that changes in recommendations frequently occur as new vaccines are developed. The AAP recommends that children get combination vaccines (rather than single vaccines) whenever possible. Many vaccines are offered in combination to help reduce the number of shots a child receives. Your doctor will determine the best vaccinations and schedule for your child. Recommended vaccinations: Hepatitis B Hepatitis B virus (HBV) affects the liver. Those who are infected can become lifelong carriers of the virus and may develop long-term problems such as cirrhosis (liver disease) or cancer of the liver. Immunization schedule Hepatitis B vaccine usually is given as a series of three injections. The first shot is often given to infants shortly after birth. If the mother of a newborn carries the hepatitis B virus in her blood, the infant needs to receive the first shot within 12 hours after birth, along with another shot (HBIG) to immediately provide protection against the virus. If a newborn's mother shows no evidence of HBV in her blood, the infant may receive the hepatitis B vaccine any time prior to leaving the hospital. It may also be delayed until the 1- or 2- month visit to your doctor. If the first dose is given shortly after birth, the second shot is given at 1 to 2 months and the third at 6 to 18 months. For infants who don't receive the first shot until 1 to 2 months, the second shot is given at 3 to 4 months and the third at 6 to 18 months. In either case, the second and third shots are usually given in conjunction with other routine childhood immunizations. Why the vaccine is recommended The hepatitis B vaccine usually creates long-term immunity. Infants who receive the HBV series should be protected from hepatitis B infection not only throughout their childhood but also into the adult years. Eliminating the risk of infection also decreases risk for cirrhosis of the liver, chronic liver disease, and liver cancer. Young adults and adolescents should also receive the vaccine if they did not as infants. Possible risks There is a very small chance of an allergic reaction with any vaccine. Serious problems associated with receiving the HBV vaccine are rare. Problems that do occur tend to be minor, such as fever or redness or tenderness at the injection site. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if a severe allergic reaction (called anaphylaxis) occurred after a previous injection of the HBV vaccine Caring for your child after immunization The vaccine may cause mild fever, and soreness and redness in the area where the shot was given. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Very young infants should not be given either medication, but for older infants or children, check with the doctor about the appropriate medication and dose. When to call the doctor * if you're not sure of the recommended schedule for the hepatitis B vaccine  * if you have concerns about your own HBV carrier state  * if serious adverse symptom appear after your child has received an HBV injection  Pneumococcal Vaccine (PCV) The pneumococcal conjugate vaccine (PCV) protects against pneumococcal infections. The bacterium is a leading cause of serious infections, including pneumonia, blood infections, and bacterial meningitis. Children under 2 years old, adults over 65 years old, and people with certain medical conditions are most susceptible to serious pneumococcal infections. The pneumococcus bacterium is spread through person-to-person contact. The vaccine not only prevents the infection in children who receive it, it also helps stop its spread. Immunization schedule PCV immunizations are given as a series of four injections starting at 2 months of age and following at 4 months, 6 months, and 12 to 15 months. Kids who miss the first dose or may have missed subsequent doses due to vaccine shortage should still receive the vaccine, and your doctor can give you a modified schedule for immunization. Why the vaccine is recommended The most serious infections affect children younger than 2 years old, and the vaccine will protect them when they're at greatest risk. PCV also is recommended for kids between 2 and 5 years of age who are at high risk for serious pneumococcal infections because they have medical problems such as: * sickle cell anemia  * a damaged spleen or no spleen  * HIV/AIDS  * cochlear implants  * a disease that affects the immune system, such as diabetes or cancer  * receiving medications that affect the immune system, such as steroids or chemotherapy  * chronic heart or lung disease  In addition, these high-risk children may also receive the pneumococcal polysaccharide vaccine (PPV) in addition to the PCV when they're older than 24 months. Possible risks Children who receive the PCV vaccine may have redness, tenderness, or swelling where the shot was given. A child may also have a fever after receiving the shot. There is a very small chance of an allergic reaction with any vaccine.  When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your child has had a severe allergic reaction to a previous dose of the vaccine  Caring for your child after immunization The vaccine may cause mild fever, and soreness and redness in the area where the shot was given. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. When to call the doctor * if your child missed a dose in the series  * if a severe allergic reaction or high fever occurs after immunization DTaP The DTaP vaccine protects against: * diphtheria \u2014 a serious infection of the throat that can block the airway and cause severe breathing difficulty  * tetanus \u2014 a nerve disease, which can occur at any age, caused by toxin-producing bacteria contaminating a wound  * pertussis (whooping cough) \u2014 a respiratory illness with cold symptoms that progress to severe coughing (the \"whooping\" sound occurs when the child breathes in deeply after a severe coughing bout); serious complications of pertussis can occur in children under 1 year of age, and those under 6 months old are especially susceptible. Teens and adults with a persistent cough may not realize they have pertussis, and may pass it to vulnerable infants.  Immunization schedule DTaP immunizations are given as a series of five injections and are usually administered at ages 2 months, 4 months, 6 months, 15 to 18 months, and 4 to 6 years. After the initial series of immunizations, a vaccine called Tdap (the booster shot) should be given at ages 11 to 12, or to older teens and adults who haven't yet received a booster with pertussis coverage. Then, Td (tetanus and diphtheria) boosters are recommended every 10 years.  Why the vaccine is recommended Use of the DTaP vaccine has virtually eliminated diphtheria and tetanus in childhood and has markedly reduced the number of pertussis cases. Possible risks The vaccine frequently causes mild side effects: fever, mild crankiness, tiredness, loss of appetite, and tenderness, redness, or swelling in the area where the shot was given. Rarely, seizures or allergic reactions can occur following DTaP. Most of these side effects result from the pertussis component of the vaccine. Severe complications caused by DTaP immunization are rare. Most kids have little or no problem. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your child has an uncontrolled seizure disorder or certain neurologic diseases or seems not to be developing normally \u2014 the pertussis component of the vaccine may not be given, and your child may receive a DT (diphtheria and tetanus) vaccine instead  If your child experienced any of the following after an earlier DTaP, consult with your doctor before your child receives another injection of the vaccine: * seizures within 7 days after injection  * worsening of seizures  * an allergic reaction after receiving the vaccine, such as mouth, throat, or facial swelling  * difficulty breathing  * temperature of 105\u00b0 Fahrenheit (40.5\u00b0 Celsius) or higher during the first 2 days after injection  * shock or collapse during the first 2 days after injection  * persistent, uncontrolled crying that lasts for more than 3 hours during the first 2 days after injection  Caring for your child after immunization Your child may experience fever, soreness, and some swelling and redness in the area where the shot was given. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. A warm, damp cloth or a heating pad also may help reduce soreness. Moving or using the limb that has received the injection often reduces the soreness. When to call the doctor * if you aren't sure whether the vaccine should be postponed or avoided. Children who have had certain problems with the DTaP vaccine usually can safely receive the DT vaccine.  * if complications or severe symptoms develop after immunization, including seizures, fever above 105\u00b0 Fahrenheit (40.5\u00b0 Celsius), difficulty breathing or other signs of allergy, shock or collapse, or uncontrolled crying for more than 3 hours  Hib Haemophilus influenzae type b bacteria were the leading cause of meningitis in children under 5 years until the Hib vaccine became available. Immunization schedule The Hib vaccine is given by injection at ages 2 months, 4 months, and 6 months (however, some of the Hib vaccines do not require a dose at 6 months). A booster dose is given at 12 to 15 months. Why the vaccine is recommended The vaccine provides long-term protection from Haemophilus influenzae type b. Those immunized have protection against Hib meningitis, pneumonia, pericarditis (an infection of the membrane covering the heart), and infections of the blood, bones, and joints caused by the bacteria. Possible risks Minor problems, such as redness, swelling, or tenderness where the shot was given, may occur. There is a very small chance of an allergic reaction with any vaccine. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if severe allergic reaction occurs after an injection of the Hib vaccine, further Hib immunizations may not be given to your child  Caring for your child after immunization The vaccine may cause mild soreness and redness in the area where the shot was given. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. When to call the doctor * if you aren't sure whether the vaccine should be postponed or avoided  * if serious adverse reactions appear after the Hib injection  IPV Polio is a viral infection that can result in permanent paralysis. Immunization schedule The inactivated poliovirus vaccine (IPV) is usually given at ages 2 months, 4 months, 6 to 18 months, and 4 to 6 years. Until recently, the oral poliovirus vaccine (OPV) was given in the United States. Updated recommendations by the Advisory Committee on Immunization Practices now call for IPV injections. This change eliminates the previous small risk of developing polio after receiving the live oral polio vaccine. Why the vaccine is recommended The vaccine offers protection against polio, which can cause paralysis and death. Possible risks Side effects include fever and redness or soreness at the site of injection. There is a very small chance of an allergic reaction with any vaccine. When to delay or avoid immunization * IPV should not be given to kids with severe allergy to neomycin, streptomycin, or polymyxin B.  * IPV should not be given to kids who had a severe allergic reaction to a previous IPV shot.  Caring for your child after immunization IPV may cause mild fever, and soreness and redness at the site of the injection for several days. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. When to call the doctor * if you aren't sure whether the vaccine should be postponed or avoided  * if severe adverse reactions occur after the immunization Influenza Influenza, or \"the flu,\" is a highly contagious viral infection of the respiratory tract. Immunization schedule Beginning in the 2010-2011 flu season, the seasonal flu vaccine protects against H1N1 flu, as well as other flu viruses. The Centers for Disease Control and Prevention (CDC) recommends the flu vaccine for all people age 6 months and older. Certain people are at higher risk of complications from the flu. They include: * pregnant women  * children younger than age 5, especially those younger than 2  * people age 65 and older  * people of any age who have chronic health conditions  Infants younger than 6 months are too young to receive the vaccine, but all other high risk persons should be vaccinated. Health care workers, caregivers, and close contacts of at-risk persons (including those who care for infants younger than 6 months) should also get the flu vaccine. In the past, there have been times when there were vaccine shortages and delays. So talk with your doctor about availability. For kids younger than 9 who are getting the seasonal influenza vaccine for the first time or did not get the H1N1 vaccine during the 2009-2010 flu season, it's given in two separate shots a month apart. It can take about 2 weeks after the shot is given for the body to build up protection against the flu. A non-shot option called the nasal mist vaccine came on the market in 2003 for the seasonal flu and is now approved for use in healthy 2- to 49-year-olds. The nasal mist contains live but weakened virus that will not cause the flu. However, the vaccine isn't recommended for kids with certain medical conditions or pregnant women. Talk to your doctor about which vaccine is right for your child. Why the vaccine is recommended The flu vaccine reduces a person's chances of catching the flu by up to 80% during the season. Getting the shot before the flu season is in full force gives the body a chance to build up immunity to, or protection from, the virus. The shot usually becomes available between September and mid-November. Although you can get a flu shot well into flu season, it's best to try to get it earlier rather than later. However, later in the flu season, it's still a good idea to get protection. Even if you or your child got the seasonal flu vaccine last year, that won't protect you from getting the seasonal flu this year, because the protection wears off and flu viruses constantly change. That's why the vaccine is updated each year to include the most current strains of the virus. A good example of how flu viruses change (and sometimes develop new strains) was the outbreak of the H1N1 flu in 2009. This flu strain was not included in the 2009-2010 seasonal flu vaccine, so a separate H1N1 flu vaccine was developed. Since then, the H1N1 flu shot has been incorporated into the seasonal flu shot.  Possible risks Usually given as an injection in the upper arm, the flu shot contains killed flu viruses that will not cause someone to get the flu, but will cause the body to make antibodies to fight off a live flu virus if it does enter the body.  Some of the most common side effects from the flu shot are soreness, redness, or swelling at the site of the injection. A low-grade fever and aches are also possible. Because the nasal spray flu vaccine is made from live viruses, it may cause mild flu-like symptoms, including runny nose, headache, vomiting, muscle aches, and fever. Very rarely, the flu vaccine can cause serious side effects such as a severe allergic reaction. When to delay or avoid immunization People who should not get the seasonal flu shot include: * infants under 6 months old  * anyone who's severely allergic to eggs and egg products. Tell the doctor if your child is allergic before he or she gets a flu shot. * anyone who's ever had a severe reaction to a flu vaccination  * anyone who's had Guillain-Barr\u00e9 syndrome (GBS, a rare medical condition that affects the nerves)  * anyone with a severe illness Caring for your child after immunization Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. Some doctors recommend a dose just before the immunization. A warm, damp cloth or a heating pad also may help minimize soreness. Moving or using the limb that has received the injection often reduces the soreness as well. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are serious problems after the immunization, such as an allergic reaction, high fever, or other concern  MMR (measles, mumps, rubella) The MMR vaccine protects against measles, mumps, and rubella (German measles). MMR vaccinations are given by injection in two doses. The first is administered at age 12 to 15 months; the second generally is given at age 4 to 6 years. Why the vaccine is recommended Measles, mumps, and rubella are infections that can lead to significant illness. More than 95% of children receiving MMR will be protected from the three diseases throughout their lives. Possible risks Serious problems such as allergic reactions are rare. Potential mild to moderate adverse effects include rash, fever, swollen cheeks, febrile seizures, and mild joint pain. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your child has an allergy to gelatin or to the antibiotic neomycin, check with your doctor about immunization  * if your child had a severe allergic reaction to a previous dose of MMR vaccine  * if your child has recently received gamma globulin or a blood transfusion, check with your doctor about immunization  * if your child has a medical problem that affects the immune system, such as cancer  * if your child is taking <em>prednisone</em>, steroids, or other immunosuppressive drugs  * if your child is undergoing chemotherapy or radiation therapy  * if your child has ever had a low platelet count, check with your doctor about immunization  * pregnant women should wait until after delivery for the vaccine  Caring for your child after immunization If a rash develops without other symptoms, no treatment is necessary and it should resolve within several days. Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and find out the appropriate dose. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization  Varicella (chickenpox) The varicella vaccine protects against chickenpox (varicella), a common and very contagious childhood viral illness. Immunization schedule The varicella vaccine is given by injection between the ages of 12 and 15 months, followed by a booster shot at 4 to 6 years of age for further protection. Older kids under the age of 13 years who have not had chickenpox may also receive the vaccine, with the two doses given at least 3 months apart. Kids 13 years or older who have not had either chickenpox or the vaccine need two vaccine doses at least 1 month apart. Why the vaccine is recommended The varicella vaccine prevents severe illness in almost all children who are immunized. It's up to 85% effective in preventing mild illness. Vaccinated kids who do get chickenpox generally have a mild case. Possible risks Serious reactions such as allergic reactions are extremely rare. Possible mild effects are tenderness and redness where the shot was given, fever, fatigue, and a varicella-like illness. A rash can occur up to 1 month after the injection. It may last for several days but will disappear on its own without treatment. There is a very small risk of febrile seizures after vaccination. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your child has an allergy to gelatin or to the antibiotic neomycin  * if your child had a severe allergic reaction to a previous dose of varicella vaccine  * if your child has recently received gamma globulin or a blood transfusion, talk to your doctor about immunization  * if your child has a disorder that affects the immune system, such as cancer; is taking <em>prednisone</em>, steroids, or other immunosuppressive drugs; or is undergoing chemotherapy or radiation therapy  * pregnant women should wait until after delivery for vaccination  Caring for your child after immunization Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and find out the appropriate dose. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization MCV4 The meningitis vaccine protects against meningococcal disease, a serious bacterial infection that can lead to bacterial meningitis. The vaccine is recommended for kids at age 11 or 12 years, at ages 13 to 18 years if not previously vaccinated, and older teens who are entering college and will be living in a dormitory setting, and those entering the military. It is also recommended for children between the ages of 2 and 10 with certain high risk medical problems. When medical problems continue, these kids also need a follow-up booster dose a few years later, depending on the age at which the first dose was given. Why the vaccine is recommended Bacterial meningitis, an inflammation of the membrane that protects the brain and spinal cord, is a rare but highly contagious disease that can spread rapidly among kids who are in close quarters. It can be life-threatening if not promptly treated. Possible risks Some of the most common side effects are swelling, redness, and pain at the site of the injection, along with headache, fever, or fatigue. Severe problems, such as allergic reactions, are rare. When to delay or avoid immunization * if your child has had allergic reactions to the DTaP vaccine or to latex  * if your child has a history of Guillain-Barr\u00e9 syndrome, a disease of the nervous system which causes progressive weakness  * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization Caring for your child after immunization Your child may experience fever, soreness, and some swelling and redness in the area where the shot was given. Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. A warm, damp cloth or a heating pad also may help reduce soreness. Moving or using the limb that has received the injection often reduces the soreness. When to Call the Doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization Hepatitis A The hepatitis A virus (HAV) causes fever, nausea, vomiting, and jaundice, and can lead to community-wide epidemics. Childcare centers are a common site of outbreaks. The vaccine is recommended for children 12 to 23 months old, followed by a second dose 6 months later. Although in the past the vaccine was recommended for older kids and adults who were at high risk for the disease (such as those who lived in or traveled to locations with high rates of HAV), the vaccine is now recommended for anyone who desires immunity to the disease. Why the vaccine is recommended Vaccination against HAV can help stop epidemics from developing in the community, in addition to protecting the individual child. Some infected children do not have any symptoms, and can spread the virus to others. The more young children who are vaccinated against HAV, the more limited the spread of disease will be in a community. Possible risks Side effects are usually mild fever, and tenderness, swelling, and redness at the site of the injection. Allergic reactions to the vaccine are rare. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization * if your child had an allergic reaction to the first dose of hepatitis A vaccine  Caring for your child after immunization Your child may experience fever, soreness, and some swelling and redness in the area where the shot was given. Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization  Rotavirus Rotavirus is a common virus that causes diarrhea, especially in infants and young children. Childcare centers are a common site of outbreaks. The vaccine, which is a liquid given by mouth, is recommended at ages 2 and 4 months, as well as a dose at 6 months depending on the brand vaccine used. Why the vaccine is recommended Rotavirus can cause dehydration secondary to large amounts of diarrhea, and can result in children requiring hospitalization. Vaccination against rotavirus can help stop spread in the community, in addition to protecting the individual child. Possible risks Side effects can include diarrhea and vomiting, in addition to fever. When to delay or avoid immunization * if your child is currently sick, although simple colds should not prevent immunization  * if your child had an allergic reaction to a previous dose of the vaccine  * let the doctor know if your child has an allergy to latex * if your child has an abnormality of the digestive system or a gastrointestinal disease, talk to your doctor about immunization  * if your child has a history of intussusception, a type of serious bowel blockage, talk to your doctor about immunization  * if your child has recently received gamma globulin or a blood transfusion  * if your child has immune system problems from a disease such as cancer; is taking steroids or other immunosuppressive drugs; or is undergoing chemotherapy or radiation therapy  Caring for your child after immunization Depending on the age of your child, fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. If vomiting or diarrhea occur, make sure to give your child frequent amounts of fluid and watch for signs of dehydration, such as less urine than usual. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization  HPV Human papillomavirus (HPV) is a sexually transmitted disease (STD) that causes genital warts and changes in the cervix that can result in cervical cancer. The vaccine is given as a series of three shots over a 6-month period and is recommended for girls 11 or 12 years old, as well as for older girls who are unvaccinated. The vaccine can also be given to boys ages 9 through 18 years, to prevent the development of genital warts.  Why the vaccine is recommended Because HPV can cause serious problems such as genital warts and cervical cancer, a vaccine is an important step in preventing infection and protecting against the spread of HPV. It works best when given before a girl becomes sexually active. Possible risks Side effects are usually mild fever and tenderness, swelling, and redness at the site of the injection. Dizziness, fainting, nausea, and vomiting may also occur after the shot. Allergic reactions to the vaccine occur rarely. When to delay or avoid immunization * if your daughter is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your daughter had an allergic reaction to the first dose of HPV vaccine  * if your daughter has had a severe allergic reaction to yeast  * if your daughter is pregnant  * if your daughter has a bleeding disorder (discuss with your hematologist)  Caring for your child after immunization Your child may experience fever, soreness, and some swelling and redness in the area where the shot was given. Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and find out the appropriate dose. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization  Immunization schedule This immunization schedule is a handy reference to help you keep track of which vaccines your child needs to receive and when. Types of vaccines Some types of vaccines are: 1. Attenuated (weakened) live viruses are used in some vaccines such as in the measles, mumps, and rubella (MMR) vaccine.  2. Killed (inactivated) viruses or bacteria are used in some vaccines, such as in IPV.  3. Toxoid vaccines contain an inactivated toxin produced by the bacterium. For example, the diphtheria and tetanus vaccines are toxoid vaccines.  4. Conjugate vaccines (such as Hib) contain parts of bacteria combined with proteins.  Immunizations for travel Specific information about which immunizations are required by travelers to each country worldwide is available directly from the Centers for Disease Control and Prevention (CDC). Ask your doctor for more information. Depending on the type and length of travel, some vaccines may be recommended. Most immunizations should be given at least 1 month before travel. Take your child's immunization records with you when you travel internationally. Helping kids through vaccine injections Sometimes it's hard to tell who dreads immunizations more \u2014 parents or kids. Here are some tips to help make the procedure easier for everyone: * Tell older kids what's going to happen and that the shot helps to keep them healthy.  * Tell younger kids that it's OK to cry, but also encourage them to be brave. * Try to be calm yourself. Your child can pick up on your concerns.  * Distraction at the moment of the injection is helpful. Try having kids count, sing a song with you, or look away (perhaps at a picture on the wall). You may want to have a joke or funny comment ready.  * Offer praise after the injection is over.  * Plan something fun for after the appointment. A trip to the park or playground can make the overall immunization experience less unpleasant.  As uneasy as getting vaccinated may make both you and your child, remember that immunizations are one of the best means of protection against contagious diseases.",
            "vi": "Ch\u1ee7ng ng\u1eeba cho con c\u1ee7a b\u1ea1n     Lu\u0301c m\u1edbi sinh, nh\u1edd kh\u00e1ng th\u1ec3 truy\u1ec1n t\u1eeb m\u1eb9 \u0111\u1ebfn thai nhi qua nhau thai n\u00ean tr\u1ebb c\u00f3 th\u1ec3 tr\u00e1nh kh\u1ecfi m\u1ed9t s\u1ed1 b\u1ec7nh n\u00e0o \u0111\u00f3. Sau khi ra \u0111\u1eddi, tr\u1ebb bu\u0301 m\u1eb9 v\u1eabn \u0111\u01b0\u1ee3c b\u1ed5 sung th\u00eam nhi\u1ec1u kh\u00e1ng th\u1ec3 c\u00f3 trong s\u1eefa m\u1eb9 giu\u0301p b\u00e9 kho\u1ebb m\u1ea1nh. Nh\u01b0ng trong c\u1ea3 hai tr\u01b0\u1eddng h\u1ee3p tr\u00ean th\u00ec s\u1ee9c b\u1ea3o v\u1ec7 cho b\u00e9 ch\u1ec9 l\u00e0 t\u1ea1m th\u1eddi trong m\u1ed9t th\u1eddi gian ng\u1eafn th\u00f4i.  Ch\u1ee7ng ng\u1eeba (ti\u00eam ch\u1ee7ng) l\u00e0 c\u00e1ch t\u1ea1o s\u1ee9c \u0111\u1ec1 kh\u00e1ng v\u1edbi m\u1ed9t s\u1ed1 b\u1ec7nh b\u1eb1ng c\u00e1ch s\u1eed d\u1ee5ng r\u1ea5t \u00edt vi sinh v\u1eadt \u0111\u00e3 ch\u1ebft ho\u1eb7c b\u1ecb l\u00e0m y\u1ebfu c\u00f3 th\u1ec3 g\u00e2y m\u1ed9t b\u1ec7nh c\u1ee5 th\u1ec3 n\u00e0o \u0111\u00f3.  Vi sinh v\u1eadt c\u00f3 th\u1ec3 l\u00e0 vi-ru\u0301t, nh\u01b0 vi-ru\u0301t s\u1edfi, ho\u1eb7c cu\u0303ng c\u00f3 th\u1ec3 l\u00e0 vi khu\u1ea9n, nh\u01b0 khu\u1ea9n c\u1ea7u ph\u1ed5i ch\u1eb3ng h\u1ea1n. C\u00e1c v\u1eafc-xin c\u00f3 t\u00e1c d\u1ee5ng l\u00e0m k\u00edch th\u00edch h\u1ec7 mi\u1ec5n d\u1ecbch ph\u1ea3n \u1ee9ng y nh\u01b0 b\u1ecb nhi\u1ec5m b\u1ec7nh th\u1eadt v\u1eady \u2013 h\u1ec7 mi\u1ec5n d\u1ecbch c\u1ee7a c\u01a1 th\u1ec3 lu\u0301c n\u00e0y s\u1ebd ch\u1ed1ng \u201cnhi\u1ec5m\u201d v\u00e0 c\u00f3 th\u1ec3 \u201cnh\u1edb \u0111\u01b0\u1ee3c\u201d lo\u1ea1i sinh v\u1eadt g\u00e2y b\u1ec7nh n\u00e0y \u0111\u1ec3 sau n\u00e0y c\u00f3 th\u1ec3 nhanh ch\u00f3ng di\u1ec7t \u0111\u01b0\u1ee3c n\u00f3 khi x\u00e2m nh\u1eadp v\u00e0o c\u01a1 th\u1ec3.  M\u1ed9t s\u1ed1 cha m\u1eb9 c\u00f3 th\u1ec3 l\u01b0\u1ee1ng l\u1ef1 kh\u00f4ng bi\u1ebft n\u00ean cho con m\u00ecnh ti\u00eam ng\u1eeba hay kh\u00f4ng b\u1edfi h\u1ecd lo r\u1eb1ng b\u00e9 s\u1ebd ph\u1ea3n \u1ee9ng l\u1ea1i v\u1eafc-xin m\u1ed9t c\u00e1ch tr\u1ea7m tr\u1ecdng ho\u1eb7c cu\u0303ng c\u00f3 th\u1ec3 b\u00e9 b\u1ecb b\u1ec7nh gi\u1ed1ng v\u1edbi b\u1ec7nh c\u1ea7n ti\u00eam ng\u1eeba. V\u00ec c\u00e1c th\u00e0nh ph\u1ea7n trong v\u1eafc-xin \u0111\u00e3 b\u1ecb l\u00e0m y\u1ebfu ho\u1eb7c \u0111\u00e3 ch\u1ebft \u2013 v\u00e0 trong m\u1ed9t v\u00e0i tr\u01b0\u1eddng h\u1ee3p th\u00ec kh\u00f4ng s\u1eed d\u1ee5ng h\u1ebft vi sinh v\u1eadt \u0111\u00f3 \u2013 chu\u0301ng kh\u00f3 c\u00f3 th\u1ec3 g\u00e2y ra m\u1ed9t ch\u1ee9ng b\u1ec7nh nguy hi\u1ec3m n\u00e0o. M\u1ed9t s\u1ed1 v\u1eafc-xin cu\u0303ng c\u00f3 th\u1ec3 g\u00e2y ra ph\u1ea3n \u1ee9ng nh\u1eb9 nh\u01b0 \u0111au nh\u1ee9c vu\u0300ng ti\u00eam ho\u1eb7c l\u00e0m cho b\u00e9 n\u00f3ng s\u1ed1t, nh\u01b0ng c\u00e1c tr\u01b0\u1eddng h\u1ee3p ph\u1ea3n \u1ee9ng n\u1eb7ng r\u1ea5t hi\u1ebfm x\u1ea3y ra.  Nh\u1eefng r\u1ee7i ro do ti\u00eam ng\u1eeba l\u00e0 r\u1ea5t \u00edt so v\u1edbi c\u00e1c v\u1ea5n \u0111\u1ec1 s\u1ee9c kh\u1ecfe do b\u1ec7nh m\u00e0 m\u00ecnh mu\u1ed1n ph\u00f2ng tr\u00e1nh g\u00e2y ra. L\u1ecbch ch\u1ee7ng ng\u1eeba d\u01b0\u1edbi \u0111\u00e2y do Vi\u1ec7n H\u00e0n L\u00e2m Nhi Khoa Hoa K\u1ef3 (AAP) khuy\u1ebfn ngh\u1ecb. Nh\u01b0ng xin l\u01b0u \u00fd l\u00e0 cu\u0303ng \u0111\u01b0\u1ee3c ph\u00e9p thay \u0111\u1ed5i v\u00e0 th\u01b0\u1eddng thay \u0111\u1ed5i khi c\u00f3 c\u00e1c lo\u1ea1i v\u1eafc-xin m\u1edbi ra \u0111\u1eddi. AAP cu\u0303ng khuy\u1ebfn ngh\u1ecb tr\u1ebb em n\u00ean ti\u00eam ng\u1eeba v\u1eafc-xin k\u1ebft h\u1ee3p (ch\u1edb kh\u00f4ng ph\u1ea3i l\u00e0 v\u1eafc-xin \u0111\u01a1n l\u1ebb) b\u1ea5t c\u1ee9 khi n\u00e0o c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c. Nhi\u1ec1u lo\u1ea1i v\u1eafc-xin k\u1ebft h\u1ee3p \u0111\u01b0\u1ee3c \u0111\u01b0a v\u00e0o s\u1eed d\u1ee5ng nh\u1eb1m giu\u0301p l\u00e0m gi\u1ea3m s\u1ed1 mu\u0303i ti\u00eam ch\u00edch cho tr\u1ebb.  B\u00e1c s\u0129 s\u1ebd quy\u1ebft \u0111\u1ecbnh xem l\u1ecbch ch\u1ee7ng ng\u1eeba n\u00e0o l\u00e0 t\u1ed1t nh\u1ea5t cho con c\u1ee7a b\u1ea1n.  L\u1ecbch ti\u00eam ch\u1ee7ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb nh\u01b0 sau: B\u1ec7nh vi\u00eam gan si\u00eau vi B Vi-ru\u0301t vi\u00eam gan si\u00eau vi B (HBV) l\u00e0m \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gan. B\u1ec7nh nh\u00e2n vi\u00eam gan si\u00eau vi B c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh ng\u01b0\u1eddi s\u1ed1ng v\u1edbi vi-ru\u0301t/ mang vi-ru\u0301t n\u00e0y su\u1ed1t \u0111\u1eddi v\u00e0 c\u00f3 th\u1ec3 ph\u00e1t sinh ra nhi\u1ec1u v\u1ea5n \u0111\u1ec1 l\u00e2u d\u00e0i nh\u01b0 l\u00e0 x\u01a1 gan (b\u1ec7nh gan) ho\u1eb7c ung th\u01b0 gan. L\u1ecbch ch\u1ee7ng ng\u1eeba V\u1eafc-xin vi\u00eam gan si\u00eau vi B th\u01b0\u1eddng \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba m\u1ed9t lo\u1ea1t 3 mu\u0303i. Tr\u1ebb s\u01a1 sinh th\u01b0\u1eddng \u0111\u01b0\u1ee3c ti\u00eam mu\u0303i \u0111\u1ea7u ti\u00ean ngay sau khi ra \u0111\u1eddi. N\u1ebfu m\u1eb9 d\u01b0\u01a1ng t\u00ednh v\u1edbi vi-ru\u0301t vi\u00eam gan si\u00eau vi B trong m\u00e1u th\u00ec tr\u1ebb m\u1edbi sinh c\u1ea7n ph\u1ea3i \u0111\u01b0\u1ee3c ti\u00eam mu\u0303i \u0111\u1ea7u trong v\u00f2ng 12 ti\u1ebfng \u0111\u1ed3ng h\u1ed3 sau khi l\u1ecdt l\u00f2ng m\u1eb9, cu\u0300ng v\u1edbi m\u1ed9t mu\u0303i (HBIG) kh\u00e1c \u0111\u1ec3 c\u00f3 th\u1ec3 kh\u00e1ng vi-ru\u0301t ngay l\u1eadp t\u1ee9c. N\u1ebfu m\u1eb9 \u00e2m t\u00ednh v\u1edbi vi-ru\u0301t vi\u00eam gan si\u00eau vi B th\u00ec tr\u1ebb s\u01a1 sinh cu\u0303ng c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba lo\u1ea1i v\u1eafc-xin n\u00e0y v\u00e0o b\u1ea5t c\u1ee9 lu\u0301c n\u00e0o tr\u01b0\u1edbc khi ra vi\u1ec7n. B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 ho\u00e3n l\u1ea1i mu\u0303i ch\u00edch n\u00e0y \u0111\u1ebfn l\u1ea7n kh\u00e1m b\u00e1c s\u0129 trong 1 hay 2 th\u00e1ng.  N\u1ebfu \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba li\u1ec1u \u0111\u1ea7u ti\u00ean sau khi sinh th\u00ec li\u1ec1u th\u1ee9 hai n\u00ean c\u00e1ch 1 \u0111\u1ebfn 2 th\u00e1ng v\u00e0 li\u1ec1u th\u1ee9 3 \u0111\u01b0\u1ee3c ti\u00eam t\u1eeb kho\u1ea3ng 6 \u0111\u1ebfn 18 th\u00e1ng. \u0110\u1ed1i v\u1edbi tr\u1ebb s\u01a1 sinh \u0111\u01b0\u1ee3c ti\u00eam mu\u0303i \u0111\u1ea7u ti\u00ean lu\u0301c 1 \u0111\u1ebfn 2 th\u00e1ng tu\u1ed5i th\u00ec mu\u0303i th\u1ee9 2 l\u00e0 kho\u1ea3ng t\u1eeb 3 \u0111\u1ebfn 4 th\u00e1ng v\u00e0 mu\u0303i th\u1ee9 ba t\u1eeb kho\u1ea3ng 6 th\u00e1ng 18 th\u00e1ng. Trong c\u1ea3 hai tr\u01b0\u1eddng h\u1ee3p th\u00ec mu\u0303i th\u1ee9 2 v\u00e0 th\u1ee9 3 th\u01b0\u1eddng \u0111\u01b0\u1ee3c ti\u00eam k\u1ebft h\u1ee3p v\u1edbi l\u1ecbch ch\u1ee7ng ng\u1eeba th\u01b0\u1eddng l\u1ec7 kh\u00e1c c\u1ee7a tr\u1ebb. T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb du\u0300ng v\u1eafc-xin  V\u1eafc-xin vi\u00eam gan si\u00eau vi B th\u01b0\u1eddng c\u00f3 th\u1ec3 t\u1ea1o mi\u1ec5n d\u1ecbch l\u00e2u d\u00e0i. Tr\u1ebb s\u01a1 sinh \u0111\u01b0\u1ee3c ti\u00eam ch\u1ee7ng HBV s\u1ebd mi\u1ec5n nhi\u1ec5m vi\u00eam gan si\u00eau vi B kh\u00f4ng ch\u1ec9 trong th\u1eddi th\u01a1 \u1ea5u m\u00e0 c\u00f2n c\u1ea3 giai \u0111o\u1ea1n tu\u1ed5i tr\u01b0\u1edfng th\u00e0nh. N\u1ebfu lo\u1ea1i tr\u1eeb \u0111\u01b0\u1ee3c nguy c\u01a1 nhi\u1ec5m b\u1ec7nh, b\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 gi\u1ea3m nguy c\u01a1 b\u1ecb x\u01a1 gan, b\u1ecb b\u1ec7nh gan m\u00e3n t\u00ednh, v\u00e0 ung th\u01b0 gan. Thanh ni\u00ean v\u00e0 thanh thi\u1ebfu ni\u00ean cu\u0303ng n\u00ean ti\u00eam ng\u1eeba v\u1eafc-xin n\u00e0y n\u1ebfu nh\u01b0 ch\u01b0a \u0111\u01b0\u1ee3c ti\u00eam l\u1ea7n n\u00e0o lu\u0301c nh\u1ecf.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin l\u00e0 r\u1ea5t \u00edt. C\u00e1c v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng li\u00ean quan \u0111\u1ebfn vi\u1ec7c ti\u00eam ng\u1eeba v\u1eafc-xin HBV r\u1ea5t hi\u1ebfm x\u1ea3y ra. Ph\u1ea3n \u1ee9ng sau khi ti\u00eam ng\u1eeba th\u01b0\u1eddng l\u00e0 r\u1ea5t nh\u1eb9, nh\u01b0 n\u00f3ng s\u1ed1t ho\u1eb7c n\u1ed5i \u0111\u1ecf ho\u1eb7c b\u1ecb \u0111au t\u1ea1i vu\u0300ng ti\u00eam ch\u00edch.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c kh\u00f4ng ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng (g\u1ecdi l\u00e0 s\u1ed1c m\u1eabn c\u1ea3m) sau l\u1ea7n ti\u00eam v\u1eafc-xin HBV tr\u01b0\u1edbc \u0111\u00e2y  Ch\u0103m s\u00f3c cho con b\u1ea1n sau khi ti\u00eam ng\u1eeba V\u1eafc-xin c\u00f3 th\u1ec3 g\u00e2y s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam ng\u1eeba. Tu\u0300y v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a b\u00e9 m\u00e0 b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 l\u00e0m gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. Tr\u1ebb s\u01a1 sinh r\u1ea5t nh\u1ecf kh\u00f4ng n\u00ean du\u0300ng thu\u1ed1c, nh\u01b0ng \u0111\u1ed1i v\u1edbi tr\u1ebb s\u01a1 sinh l\u1edbn h\u01a1n ho\u1eb7c tr\u1ebb nh\u1ecf th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 thu\u1ed1c v\u00e0 li\u1ec1u du\u0300ng th\u00edch h\u1ee3p cho b\u00e9 nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n ch\u01b0a r\u00f5 v\u1ec1 l\u1ecbch ch\u1ee7ng ng\u1eeba v\u1eafc-xin vi\u00eam gan si\u00eau vi B  * n\u1ebfu b\u1ea1n lo l\u1eafng v\u1ec1 t\u00ecnh tr\u1ea1ng mang m\u1ea7m vi-ru\u0301t HBV c\u1ee7a m\u00ecnh * n\u1ebfu b\u1ea1n th\u1ea5y b\u1ea5t c\u1ee9 tri\u1ec7u ch\u1ee9ng \u1ea3nh h\u01b0\u1edfng x\u1ea5u nghi\u00eam tr\u1ecdng n\u00e0o \u0111\u1ed1i v\u1edbi con b\u1ea1n sau khi b\u00e9 ti\u00eam ng\u1eeba HBV V\u1eafc-xin ch\u1ed1ng khu\u1ea9n c\u1ea7u ph\u1ed5i (PCV) V\u1eafc-xin c\u1ed9ng h\u1ee3p ph\u1ebf c\u1ea7u (PCV) c\u00f3 t\u00e1c d\u1ee5ng ch\u1ed1ng nhi\u1ec5m khu\u1ea9n c\u1ea7u ph\u1ed5i. Vi khu\u1ea9n l\u00e0 nguy\u00ean nh\u00e2n h\u00e0ng \u0111\u1ea7u c\u1ee7a nhi\u1ec1u ch\u1ee9ng nhi\u1ec5m tru\u0300ng nghi\u00eam tr\u1ecdng, nh\u01b0 vi\u00eam ph\u1ed5i, nhi\u1ec5m tru\u0300ng m\u00e1u, v\u00e0 vi\u00eam m\u00e0ng n\u00e3o do vi khu\u1ea9n. Tr\u1ebb em d\u01b0\u1edbi 2 tu\u1ed5i, ng\u01b0\u1eddi l\u1edbn tr\u00ean 65 tu\u1ed5i, v\u00e0 ng\u01b0\u1eddi \u0111ang m\u1eafc m\u1ed9t s\u1ed1 b\u1ec7nh n\u00e0o \u0111\u00f3 d\u1ec5 b\u1ecb nhi\u1ec5m khu\u1ea9n c\u1ea7u ph\u1ed5i nhi\u1ec1u nh\u1ea5t. khu\u1ea9n c\u1ea7u ph\u1ed5i l\u00e2y qua ti\u1ebfp xu\u0301c t\u1eeb ng\u01b0\u1eddi sang ng\u01b0\u1eddi. V\u1eafc-xin c\u1ed9ng h\u1ee3p ph\u1ebf c\u1ea7u kh\u00f4ng nh\u1eefng giu\u0301p tr\u1ebb tr\u00e1nh nhi\u1ec5m b\u1ec7nh m\u00e0 c\u00f2n ng\u0103n ch\u1eb7n l\u00e2y lan.  L\u1ecbch ch\u1ee7ng ng\u1eeba Ch\u1ee7ng ng\u1eeba PCV \u0111\u01b0\u1ee3c ti\u00eam th\u00e0nh m\u1ed9t lo\u1ea1t 4 mu\u0303i, b\u1eaft \u0111\u1ea7u t\u1eeb 2 th\u00e1ng tu\u1ed5i, 4 th\u00e1ng tu\u1ed5i, 6 th\u00e1ng tu\u1ed5i, v\u00e0 t\u1eeb 12 \u0111\u1ebfn 15 th\u00e1ng tu\u1ed5i. Tr\u1ebb b\u1ecf l\u1ee1 li\u1ec1u v\u1eafc-xin \u0111\u1ea7u ti\u00ean ho\u1eb7c c\u00f3 th\u1ec3 \u0111\u00e3 kh\u00f4ng ch\u00edch \u0111\u01b0\u1ee3c c\u00e1c li\u1ec1u sau do thi\u1ebfu v\u1eafc-xin th\u00ec v\u1eabn s\u1ebd \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba, v\u00e0 b\u00e1c s\u0129 s\u1ebd cho b\u1ea1n bi\u1ebft l\u1ecbch ti\u00eam ch\u1ee7ng c\u00f3 thay \u0111\u1ed5i c\u1ee7a m\u00ecnh. T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb du\u0300ng v\u1eafc-xin  tr\u1ebb d\u01b0\u1edbi 2 tu\u1ed5i th\u01b0\u1eddng hay m\u1eafc h\u1ea7u h\u1ebft c\u00e1c b\u1ec7nh nhi\u1ec5m tru\u0300ng n\u1eb7ng, v\u00e0 v\u1eafc-xin s\u1ebd giu\u0301p cho tr\u1ebb ph\u00f2ng tr\u00e1nh \u0111\u01b0\u1ee3c c\u00e1c b\u1ec7nh \u0111\u00f3 khi c\u00f3 nguy c\u01a1 l\u00e2y nhi\u1ec5m nhi\u1ec1u nh\u1ea5t.  PCV cu\u0303ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb ti\u00eam ph\u00f2ng cho tr\u1ebb t\u1eeb 2 \u0111\u1ebfn 5 tu\u1ed5i \u0111ang c\u00f3 nguy c\u01a1 nhi\u1ec5m khu\u1ea9n c\u1ea7u ph\u1ed5i n\u1eb7ng v\u00ec c\u00f3 th\u1ec3 g\u00e2y nhi\u1ec1u v\u1ea5n \u0111\u1ec1 v\u1ec1 s\u1ee9c kh\u1ecfe nh\u01b0:  * b\u1ec7nh thi\u1ebfu m\u00e1u h\u1ed3ng c\u1ea7u h\u00ecnh li\u1ec1m * l\u00e1 l\u00e1ch b\u1ecb h\u01b0 ho\u1eb7c kh\u00f4ng c\u00f3 l\u00e1 l\u00e1ch * HIV/AIDS * ph\u1ea3i du\u0300ng thi\u1ebft b\u1ecb tr\u1ee3 th\u00ednh \u0111\u01b0\u1ee3c c\u1ea5y d\u01b0\u1edbi da * b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u1ec7 mi\u1ec5n d\u1ecbch, nh\u01b0 ti\u1ec3u \u0111\u01b0\u1eddng ho\u1eb7c ung th\u01b0 * ph\u1ea3i du\u0300ng thu\u1ed1c \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u1ec7 mi\u1ec5n d\u1ecbch, nh\u01b0 l\u00e0 xt\u00ea-r\u00f4-it ho\u1eb7c ho\u00e1 tr\u1ecb li\u1ec7u * b\u1ecb b\u1ec7nh tim m\u00e3n t\u00ednh ho\u1eb7c b\u1ec7nh v\u1ec1 ph\u1ed5i Ngo\u00e0i ra, nh\u1eefng tr\u1ebb em c\u00f3 nguy c\u01a1 nhi\u1ec5m b\u1ec7nh cao cu\u0303ng c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba v\u1eafc-xin p\u00f4-li-xa-ca-r\u00edt khu\u1ea9n c\u1ea7u ph\u1ed5i (PPV) ngo\u00e0i v\u1eafc-xin PCV khi \u0111\u00e3 tr\u00ean 24 th\u00e1ng tu\u1ed5i.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra Tr\u1ebb \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba v\u1eafc-xin PCV cu\u0303ng c\u00f3 th\u1ec3 b\u1ecb n\u1ed5i \u0111\u1ecf, \u0111au nh\u1ee9c, ho\u1eb7c s\u01b0ng \u1edf vu\u0300ng ti\u00eam ho\u1eb7c cu\u0303ng c\u00f3 th\u1ec3 b\u1ecb n\u00f3ng s\u1ed1t sau khi ti\u00eam ng\u1eeba. Tr\u01b0\u1eddng h\u1ee3p ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin r\u1ea5t hi\u1ebfm khi x\u1ea3y ra.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi li\u1ec1u v\u1eafc-xin tr\u01b0\u1edbc  Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba V\u1eafc-xin n\u00e0y c\u00f3 th\u1ec3 g\u00e2y s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n, b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen hay ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 xem li\u1ec7u c\u00f3 th\u1ec3 cho b\u00e9 du\u0300ng thu\u1ed1c g\u00ec, v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p v\u1edbi b\u00e9 nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu con b\u1ea1n b\u1ecf l\u1ee1 m\u1ed9t l\u1ea7n ti\u00eam * n\u1ebfu sau khi ti\u00eam ng\u1eeba b\u00e9 b\u1ecb ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng ho\u1eb7c s\u1ed1t cao DTaP V\u1eafc-xin DTaP giu\u0301p ph\u00f2ng tr\u00e1nh: * b\u1ea1ch h\u1ea7u \u2013 \u0111\u00e2y l\u00e0 ch\u1ee9ng nhi\u1ec5m tru\u0300ng h\u1ecdng nghi\u00eam tr\u1ecdng c\u00f3 th\u1ec3 g\u00e2y ngh\u1ebdn \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p hay ngh\u1ebdn kh\u00ed qu\u1ea3n v\u00e0 g\u00e2y kh\u00f3 th\u1edf d\u1eef d\u1ed9i  * u\u1ed1n v\u00e1n \u2013 \u0111\u00e2y l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh th\u1ea7n kinh, c\u00f3 th\u1ec3 x\u1ea3y ra \u1edf m\u1ecdi l\u1ee9a tu\u1ed5i, do \u0111\u1ed9c t\u1ed1 t\u1ea1o khu\u1ea9n l\u00e0m nhi\u1ec5m tru\u0300ng v\u1ebft th\u01b0\u01a1ng (u\u1ed1n v\u00e1n l\u00e0 m\u1ed9t b\u1ec7nh do vi khu\u1ea9n qua v\u1ebft th\u01b0\u01a1ng x\u00e2m nh\u1eadp v\u00e0o c\u01a1 th\u1ec3, g\u00e2y n\u00ean nh\u1eefng c\u01a1n co gi\u1eadt, kh\u00f3 th\u1edf v\u00e0 d\u1ec5 d\u1eabn \u0111\u1ebfn t\u1eed vong) * ho g\u00e0 \u2013 l\u00e0 m\u1ed9t b\u1ec7nh v\u1ec1 \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p v\u1edbi c\u00e1c tri\u1ec7u ch\u1ee9ng c\u1ee7a b\u1ec7nh cu\u0301m ph\u00e1t tri\u1ec3n ng\u00e0y c\u00e0ng t\u0103ng d\u1eabn \u0111\u1ebfn ho d\u1eef d\u1ed9i (nghe nh\u01b0 ti\u1ebfng kh\u00f2 kh\u00e8 khi tr\u1ebb h\u00edt s\u00e2u v\u00e0o sau m\u1ed9t c\u01a1n ho ru\u0303 r\u01b0\u1ee3i); tr\u1ebb d\u01b0\u1edbi 1 tu\u1ed5i th\u01b0\u1eddng x\u1ea3y ra nhi\u1ec1u bi\u1ebfn ch\u1ee9ng ho g\u00e0 tr\u1ea7m tr\u1ecdng, v\u00e0 tr\u1ebb d\u01b0\u1edbi 6 th\u00e1ng tu\u1ed5i cu\u0303ng r\u1ea5t hay nhi\u1ec5m b\u1ec7nh n\u00e0y. Thi\u1ebfu ni\u00ean v\u00e0 ng\u01b0\u1eddi l\u1edbn b\u1ecb ho dai d\u1eb3ng cu\u0303ng c\u00f3 th\u1ec3 kh\u00f4ng bi\u1ebft m\u00ecnh b\u1ecb ho g\u00e0, v\u00e0 cu\u0303ng c\u00f3 th\u1ec3 l\u00e0m l\u00e2y sang cho tr\u1ebb s\u01a1 sinh d\u1ec5 m\u1eafc b\u1ec7nh.  L\u1ecbch ch\u1ee7ng ng\u1eeba Ch\u1ee7ng ng\u1eeba DTaP \u0111\u01b0\u1ee3c ti\u00eam th\u00e0nh 1 lo\u1ea1t 5 mu\u0303i v\u00e0 th\u01b0\u1eddng b\u1eaft \u0111\u1ea7u lu\u0301c 2 th\u00e1ng tu\u1ed5i, 4 th\u00e1ng tu\u1ed5i, 6 th\u00e1ng tu\u1ed5i, t\u1eeb 15 \u0111\u1ebfn 18 th\u00e1ng tu\u1ed5i, v\u00e0 t\u1eeb 4 \u0111\u1ebfn 6 tu\u1ed5i. Sau lo\u1ea1t ch\u1ee7ng ng\u1eeba \u0111\u1ea7u ti\u00ean, v\u1eafc-xin Tdap (ti\u00eam nh\u1eafc) s\u1ebd \u0111\u01b0\u1ee3c ti\u00eam nh\u1eafc l\u1ea1i cho \u0111\u1ed9 tu\u1ed5i t\u1eeb 11 \u0111\u1ebfn 12, ho\u1eb7c cho thi\u1ebfu ni\u00ean l\u1edbn tu\u1ed5i h\u01a1n v\u00e0 ng\u01b0\u1eddi l\u1edbn ch\u01b0a ti\u00eam nh\u1eafc ng\u1eeba b\u1ec7nh ho g\u00e0 l\u1ea1i. K\u1ebf \u0111\u1ebfn l\u00e0 c\u00e1c mu\u0303i ti\u00eam nh\u1eafc ng\u1eeba u\u1ed1n v\u00e1n, b\u1ea1ch h\u1ea7u cu\u0303ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb l\u00e0 c\u1ee9 sau 10 n\u0103m m\u1ed9t l\u1ea7n.  T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin Vi\u1ec7c ch\u1ee7ng ng\u1eeba v\u1eafc-xin DtaP h\u1ea7u nh\u01b0 \u0111\u00e3 giu\u0301p tr\u1ebb kh\u00f4ng c\u00f2n m\u1eafc b\u1ec7nh b\u1ea1ch h\u1ea7u v\u00e0 u\u1ed1n v\u00e1n \u1edf tr\u1ebb em v\u00e0 \u0111\u00e3 l\u00e0m gi\u1ea3m \u0111\u00e1ng k\u1ec3 s\u1ed1 ca m\u1eafc ch\u1ee9ng ho g\u00e0. R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra V\u1eafc-xin ch\u1ee7ng ng\u1eeba th\u01b0\u1eddng g\u00e2y t\u00e1c d\u1ee5ng ph\u1ee5 nh\u1eb9 nh\u01b0 n\u00f3ng s\u1ed1t, h\u01a1i m\u1ec7t, m\u1ec7t m\u1ecfi, ch\u00e1n \u0103n, v\u00e0 \u0111au nh\u1ee9c, n\u1ed5i \u0111\u1ecf ho\u1eb7c l\u00e0m s\u01b0ng \u1edf vu\u0300ng ti\u00eam. C\u00e1c tr\u01b0\u1eddng h\u1ee3p tai bi\u1ebfn ng\u1eadp m\u00e1u hay ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng sau khi ti\u00eam DTaP l\u00e0 r\u1ea5t hi\u1ebfm x\u1ea3y ra. H\u1ea7u h\u1ebft c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 n\u00e0y l\u00e0 do c\u00e1c th\u00e0nh ph\u1ea7n trong v\u1eafc-xin ng\u1eeba ho g\u00e0. C\u00e1c bi\u1ebfn ch\u1ee9ng nghi\u00eam tr\u1ecdng do ch\u1ee7ng ng\u1eeba DTaP r\u1ea5t hi\u1ebfm. Ph\u1ea7n l\u1edbn tr\u1ebb em \u0111\u1ec1u g\u1eb7p r\u1ea5t \u00edt s\u1ef1 c\u1ed1 ho\u1eb7c kh\u00f4ng c\u00f3 v\u1ea5n \u0111\u1ec1 g\u00ec. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba  * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb \u0111\u1ed9ng kinh kh\u00f4ng k\u1ec1m ch\u1ebf \u0111\u01b0\u1ee3c ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh th\u1ea7n kinh n\u00e0o \u0111\u00f3 ho\u1eb7c c\u00f3 v\u1ebb nh\u01b0 ph\u00e1t tri\u1ec3n kh\u00f4ng b\u00ecnh th\u01b0\u1eddng th\u00ec cu\u0303ng kh\u00f4ng n\u00ean ti\u1ebfp xu\u0301c v\u1edbi v\u1eafc-xin ho g\u00e0, b\u00e9 c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ti\u00eam v\u1eafc-xin DT (b\u1ea1ch h\u1ea7u, u\u1ed1n v\u00e1n) thay cho v\u1eafc-xin DTaP.  N\u1ebfu con b\u1ea1n b\u1ecb b\u1ea5t k\u1ef3 tri\u1ec7u ch\u1ee9ng g\u00ec sau khi ti\u00eam DTaP \u1edf l\u1ea7n tr\u01b0\u1edbc, b\u1ea1n h\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 tr\u01b0\u1edbc khi cho b\u00e9 ti\u00eam m\u1ed9t lo\u1ea1i v\u1eafc-xin n\u00e0o kh\u00e1c nh\u00e9: * tai bi\u1ebfn ng\u1eadp m\u00e1u trong v\u00f2ng 7 ng\u00e0y sau khi ti\u00eam * tai bi\u1ebfn ng\u1eadp m\u00e1u ng\u00e0y c\u00e0ng d\u1eef d\u1ed9i h\u01a1n * ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng sau khi ti\u00eam v\u1eafc-xin, nh\u01b0 l\u00e0 mi\u1ec7ng, h\u1ecdng, ho\u1eb7c m\u1eb7t s\u01b0ng l\u00ean  * kh\u00f3 th\u1edf * s\u1ed1t 105\u00b0 Pha-ren-het (40.5\u00b0 C) tr\u1edf l\u00ean trong 2 ng\u00e0y \u0111\u1ea7u sau khi ti\u00eam  * s\u1ed1c ho\u1eb7c suy nh\u01b0\u1ee3c trong 2 ng\u00e0y \u0111\u1ea7u ti\u00ean sau khi ti\u00eam * kh\u00f3c dai d\u1eb3ng kh\u00f4ng n\u00edn h\u01a1n 3 ti\u1ebfng \u0111\u1ed3ng h\u1ed3 trong 2 ng\u00e0y \u0111\u1ea7u ti\u00ean sau khi ti\u00eam Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba Con b\u1ea1n c\u00f3 th\u1ec3 b\u1ecb n\u00f3ng s\u1ed1t, \u0111au nh\u1ee9c v\u00e0 s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n, b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 l\u00e0m gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n h\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 cho b\u00e9 s\u1eed d\u1ee5ng lo\u1ea1i thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o cho phu\u0300 h\u1ee3p v\u1edbi b\u00e9 nh\u00e9. B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 du\u0300ng mi\u1ebfng gi\u1ebb \u1ea9m, \u1ea5m ho\u1eb7c mi\u1ebfng l\u00f3t n\u00f3ng \u0111\u1ec3 l\u00e0m gi\u1ea3m \u0111au. Vi\u1ec7c nhu\u0301c nh\u00edch, c\u1eed \u0111\u1ed9ng ch\u00e2n tay c\u00f3 vu\u0300ng ti\u00eam ng\u1eeba cu\u0303ng th\u01b0\u1eddng giu\u0301p b\u1ea1n gi\u1ea3m \u0111au. Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129 * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh v\u1eafc-xin ch\u1ee7ng ng\u1eeba n\u00e0y hay kh\u00f4ng. Tr\u1ebb em t\u1eebng g\u1eb7p s\u1ef1 c\u1ed1 n\u00e0o \u0111\u00f3 v\u1edbi v\u1eafc-xin DtaP th\u01b0\u1eddng c\u00f3 th\u1ec3 ti\u00eam ng\u1eeba an to\u00e0n v\u1edbi v\u1eafc-xin DT.  * n\u1ebfu x\u1ea3y ra c\u00e1c bi\u1ebfn ch\u1ee9ng hay c\u00e1c tri\u1ec7u ch\u1ee9ng tr\u1ea7m tr\u1ecdng sau khi ti\u00eam ng\u1eeba nh\u01b0 tai bi\u1ebfn ng\u1eadp m\u00e1u, s\u1ed1t tr\u00ean 105\u00b0 Pha-ren-het (40.5\u00b0 C), kh\u00f3 th\u1edf ho\u1eb7c c\u00f3 c\u00e1c d\u1ea5u hi\u1ec7u d\u1ecb \u1ee9ng kh\u00e1c, s\u1ed1c hay b\u1ea5t t\u1ec9nh (x\u1ec9u), ho\u1eb7c kh\u00f3c dai d\u1eb3ng kh\u00f4ng n\u00edn h\u01a1n 3 ti\u1ebfng \u0111\u1ed3ng h\u1ed3 Hib Tr\u01b0\u1edbc khi v\u1eafc-xin Hib ra \u0111\u1eddi th\u00ec vi khu\u1ea9n g\u00e2y vi\u00eam m\u00e0ng n\u00e3o mu\u0303 do HIB lo\u1ea1i B l\u00e0 nguy\u00ean nh\u00e2n h\u00e0ng \u0111\u1ea7u g\u00e2y vi\u00eam m\u00e0ng n\u00e3o \u1edf tr\u1ebb d\u01b0\u1edbi 5 tu\u1ed5i.\u00a0  L\u1ecbch ch\u1ee7ng ng\u1eeba V\u1eafc-xin Hib \u0111\u01b0\u1ee3c ti\u00eam \u1edf giai \u0111o\u1ea1n 2 th\u00e1ng tu\u1ed5i, 4 th\u00e1ng tu\u00f4it, v\u00e0 6 th\u00e1ng tu\u1ed5i (tuy nhi\u00ean, m\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin Hib kh\u00f4ng y\u00eau c\u1ea7u ph\u1ea3i ti\u00eam th\u00eam li\u1ec1u \u1edf th\u00e1ng th\u1ee9 6). Tr\u1ebb n\u00ean \u0111\u01b0\u1ee3c ti\u00eam nh\u1eafc l\u1ea1i m\u1ed9t l\u1ea7n t\u1eeb th\u00e1ng 12 \u0111\u1ebfn th\u00e1ng 15.  T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin V\u1eafc-xin Hib c\u00f3 th\u1ec3 giu\u0301p ph\u00f2ng tr\u00e1nh vi\u00eam m\u00e0ng n\u00e3o mu\u0303 do HIB lo\u1ea1i B trong th\u1eddi gian l\u00e2u d\u00e0i. Ng\u01b0\u1eddi \u0111\u01b0\u1ee3c ch\u1ee7ng ng\u1eeba tr\u00e1nh \u0111\u01b0\u1ee3c b\u1ec7nh vi\u00eam m\u00e0ng n\u00e3o Hib, vi\u00eam ph\u1ed5i, vi\u00eam m\u00e0ng ngo\u00e0i tim (vi\u00eam m\u00e0ng tim), v\u00e0 nhi\u1ec5m tru\u0300ng m\u00e1u, x\u01b0\u01a1ng v\u00e0 kh\u1edbp do vi khu\u1ea9n g\u00e2y ra.\u00a0  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra Cu\u0303ng c\u00f3 nhi\u1ec1u v\u1ea5n \u0111\u1ec1 nh\u1ecf sau khi ti\u00eam ng\u1eeba, nh\u01b0 b\u00e9 s\u1ebd c\u00f3 th\u1ec3 n\u1ed5i \u0111\u1ecf, s\u01b0ng ho\u1eb7c \u0111au nh\u1ee9c \u1edf vu\u0300ng ti\u00eam. Tr\u01b0\u1eddng h\u1ee3p ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin r\u1ea5t hi\u1ebfm khi x\u1ea3y ra. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng sau khi ti\u00eam v\u1eafc-xin Hib th\u00ec ch\u1edb n\u00ean cho b\u00e9 ti\u00eam th\u00eam Hib l\u1ea7n sau n\u1eefa Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba V\u1eafc-xin Hib c\u00f3 th\u1ec3 g\u00e2y \u0111au nh\u1ee9c nh\u1eb9 hay n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n, b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u n\u00ean cho b\u00e9 du\u0300ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p v\u1edbi b\u00e9 nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi \u0111i\u1ec7n cho b\u00e1c s\u0129 * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh kh\u00f4ng ti\u00eam ng\u1eeba lo\u1ea1i v\u1eafc-xin n\u00e0y * n\u1ebfu th\u1ea5y c\u00e1c ph\u1ea3n \u1ee9ng x\u1ea5u nghi\u00eam tr\u1ecdng sau khi ti\u00eam ng\u1eeba Hib  IPV B\u1ec7nh b\u1ea1i li\u1ec7t l\u00e0 b\u1ec7nh nhi\u1ec5m vi-ru\u0301t c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn b\u1ea1i li\u1ec7t su\u1ed1t \u0111\u1eddi. L\u1ecbch ch\u1ee7ng ng\u1eeba V\u1eafc-xin ng\u1eeba b\u1ea1i li\u1ec7t b\u1ea5t ho\u1ea1t th\u01b0\u1eddng \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba \u1edf giai \u0111o\u1ea1n 2 th\u00e1ng tu\u1ed5i, 4 th\u00e1ng tu\u1ed5i, t\u1eeb 6 th\u00e1ng \u0111\u1ebfn 18 th\u00e1ng tu\u1ed5i, v\u00e0 t\u1eeb 4 \u0111\u1ebfn 6 tu\u1ed5i.  G\u1ea7n \u0111\u00e2y v\u1eafc-xin ng\u1eeba b\u1ea1i li\u1ec7t d\u1ea1ng u\u1ed1ng \u0111\u00e3 \u0111\u01b0\u1ee3c \u0111\u01b0a v\u00e0o s\u1eed d\u1ee5ng \u1edf Hoa K\u1ef3. U\u1ef7 ban c\u1ed1 v\u1ea5n v\u1ec1 ch\u1ee7ng ng\u1eeba m\u1edbi \u0111\u00e2y \u0111\u00e3 y\u00eau c\u1ea7u n\u00ean ti\u00eam IPV. S\u1ef1 thay \u0111\u1ed5i n\u00e0y \u0111\u00e3 l\u00e0m d\u1ee9t nguy c\u01a1 r\u1ea5t \u00edt v\u1ec1 b\u1ec7nh b\u1ea1i li\u1ec7t tr\u01b0\u1edbc \u0111\u00e2y sau khi du\u0300ng v\u1eafc-xin b\u1ea1i li\u1ec7t s\u1ed1ng d\u1ea1ng u\u1ed1ng. T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin V\u1eafc-xin giu\u0301p ph\u00f2ng tr\u00e1nh \u0111\u01b0\u1ee3c b\u1ec7nh b\u1ea1i li\u1ec7t c\u00f3 th\u1ec3 g\u00e2y li\u1ec7t v\u00e0 t\u1eed vong. R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 nh\u01b0 n\u00f3ng s\u1ed1t v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. R\u1ea5t \u00edt khi x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * kh\u00f4ng n\u00ean ti\u00eam IPV cho tr\u1ebb b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi neomycin, streptomycin, ho\u1eb7c polymyxin B. * kh\u00f4ng n\u00ean ti\u00eam IPV cho tr\u1ebb b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi li\u1ec1u ti\u00eam IPV tr\u01b0\u1edbc Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba IPV c\u00f3 th\u1ec3 g\u00e2y ra s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam trong m\u1ed9t v\u00e0i ng\u00e0y. Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n, b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem n\u00ean cho b\u00e9 s\u1eed d\u1ee5ng lo\u1ea1i thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u du\u0300ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft li\u1ec7u n\u00ean ho\u00e3n hay kh\u00f4ng ti\u00eam ch\u1ee7ng lo\u1ea1i v\u1eafc-xin n\u00e0y * n\u1ebfu c\u00f3 b\u1ea5t k\u1ef3 ph\u1ea3n \u1ee9ng x\u1ea5u nghi\u00eam tr\u1ecdng n\u00e0o x\u1ea3y ra sau khi ti\u00eam ng\u1eeba Cu\u0301m Cu\u0301m l\u00e0 ch\u1ee9ng b\u1ec7nh nhi\u1ec5m tru\u0300ng \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p do vi ru\u0301t g\u00e2y ra v\u00e0 l\u00e2y lan r\u1ea5t nhanh. L\u1ecbch ch\u1ee7ng ng\u1eeba B\u1eaft \u0111\u1ea7u mu\u0300a cu\u0301m 2010-2011 m\u1edbi c\u00f3 v\u1eafc-xin cu\u0301m mu\u0300a ng\u1eeba cu\u0301m H1N1 cu\u0303ng nh\u01b0 c\u00e1c lo\u1ea1i vi ru\u0301t cu\u0301m kh\u00e1c. Trung t\u00e2m ph\u00f2ng ch\u1ed1ng b\u1ec7nh t\u1eadt (CDC) khuy\u1ebfn c\u00e1o n\u00ean ti\u00eam ng\u1eeba v\u1eafc-xin cu\u0301m cho t\u1ea5t c\u1ea3 m\u1ecdi ng\u01b0\u1eddi t\u1eeb 6 th\u00e1ng tu\u1ed5i tr\u1edf l\u00ean. M\u1ed9t s\u1ed1 ng\u01b0\u1eddi c\u00f3 nguy c\u01a1 bi\u1ebfn ch\u1ee9ng cu\u0301m cao h\u01a1n g\u1ed3m:  * ph\u1ee5 n\u1eef c\u00f3 thai * tre\u0309 em d\u01b0\u1edbi 5 tu\u1ed5i, nh\u1ea5t l\u00e0 tr\u1ebb d\u01b0\u1edbi 2 tu\u1ed5i * ng\u01b0\u1eddi gi\u00e0 t\u1eeb 65 tu\u1ed5i tr\u1edf l\u00ean * ng\u01b0\u1eddi b\u1ecb b\u1ec7nh m\u00e3n t\u00ednh \u1edf b\u1ea5t k\u1ef3 \u0111\u1ed9 tu\u1ed5i n\u00e0o Tr\u1ebb s\u01a1 sinh d\u01b0\u1edbi 6 th\u00e1ng tu\u1ed5i qu\u00e1 nh\u1ecf kh\u00f4ng ti\u00eam ng\u1eeba v\u1eafc-xin \u0111\u01b0\u1ee3c, nh\u01b0ng t\u1ea5t c\u1ea3 nh\u1eefng ng\u01b0\u1eddi c\u00f3 nguy c\u01a1 m\u1eafc b\u1ec7nh cao kh\u00e1c n\u00ean \u0111\u01b0\u1ee3c ti\u00eam ph\u00f2ng. C\u00e1c nh\u00e2n vi\u00ean ch\u0103m s\u00f3c y t\u1ebf, ng\u01b0\u1eddi ch\u0103m b\u1ec7nh, v\u00e0 ng\u01b0\u1eddi th\u01b0\u1eddng hay ti\u1ebfp xu\u0301c g\u1ea7n gu\u0303i v\u1edbi ng\u01b0\u1eddi c\u00f3 nguy c\u01a1 nhi\u1ec5m b\u1ec7nh cao (k\u1ec3 c\u1ea3 ng\u01b0\u1eddi ch\u0103m s\u00f3c tr\u1ebb s\u01a1 sinh d\u01b0\u1edbi 6 th\u00e1ng tu\u1ed5i) cu\u0303ng n\u00ean ti\u00eam ng\u1eeba v\u1eafc-xin. Tr\u01b0\u1edbc \u0111\u00e2y \u0111\u00e3 c\u00f3 t\u00ecnh tr\u1ea1ng thi\u1ebfu v\u00e0 ph\u1ea3i ho\u00e3n v\u1eafc-xin. V\u00ec v\u1eady b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 xem v\u1eafc-xin c\u00f3 s\u1eb5n ch\u01b0a nh\u00e9.  \u0110\u1ed1i v\u1edbi tr\u1ebb d\u01b0\u1edbi 9 tu\u1ed5i chu\u1ea9n b\u1ecb ti\u00eam ng\u1eeba v\u1eafc-xin cu\u0301m mu\u0300a l\u1ea7n \u0111\u1ea7u ti\u00ean ho\u1eb7c ch\u01b0a ti\u00eam ch\u1ee7ng v\u1eafc-xin H1N1 trong mu\u0300a cu\u0301m n\u0103m 2009-2010 th\u00ec s\u1ebd \u0111\u01b0\u1ee3c ti\u00eam th\u00e0nh 2 mu\u0303i ri\u00eang bi\u1ec7t c\u00e1ch nhau 1 th\u00e1ng. C\u00f3 th\u1ec3 ph\u1ea3i m\u1ea5t kho\u1ea3ng 2 tu\u1ea7n sau khi ti\u00eam v\u1eafc-xin th\u00ec c\u01a1 th\u1ec3 m\u1edbi c\u00f3 th\u1ec3 mi\u1ec5n d\u1ecbch \u0111\u01b0\u1ee3c v\u1edbi cu\u0301m.  B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 ch\u1ecdn m\u1ed9t d\u1ea1ng v\u1eafc-xin ph\u00f2ng ch\u1ed1ng cu\u0301m kh\u00e1c m\u00e0 kh\u00f4ng ph\u1ea3i ti\u00eam ch\u00edch \u0111\u00f3 l\u00e0 v\u1eafc-xin d\u1ea1ng x\u1ecbt v\u00e0o mu\u0303i \u0111\u00e3 \u0111\u01b0\u1ee3c tung ra th\u1ecb tr\u01b0\u1eddng n\u0103m 2003 \u0111\u1ec3 ng\u1eeba d\u1ecbch cu\u0301m mu\u0300a v\u00e0 hi\u1ec7n \u0111ang \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 ch\u1ed1ng cu\u0301m cho ng\u01b0\u1eddi kh\u1ecfe m\u1ea1nh t\u1eeb 2 \u0111\u1ebfn 49 tu\u1ed5i. V\u1eafc-xin d\u1ea1ng x\u1ecbt v\u00e0o mu\u0303i ch\u1ee9a vi-ru\u0301t c\u00f2n s\u1ed1ng nh\u01b0ng \u0111\u00e3 b\u1ecb l\u00e0m y\u1ebfu \u0111i v\u00e0 s\u1ebd kh\u00f4ng g\u00e2y cu\u0301m. Tuy nhi\u00ean, tr\u1ebb b\u1ecb m\u1eafc m\u1ed9t ch\u1ee9ng b\u1ec7nh n\u00e0o \u0111\u00f3 ho\u1eb7c ph\u1ee5 n\u1eef c\u00f3 thai th\u00ec kh\u00f4ng n\u00ean s\u1eed d\u1ee5ng d\u1ea1ng v\u1eafc-xin n\u00e0y. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 bi\u1ebft lo\u1ea1i v\u1eafc-xin n\u00e0o l\u00e0 phu\u0300 h\u1ee3p cho con c\u1ee7a m\u00ecnh nh\u00e9.  T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin  V\u1eafc-xin ng\u1eeba cu\u0301m c\u00f3 th\u1ec3 giu\u0301p l\u00e0m gi\u1ea3m nguy c\u01a1 m\u1eafc b\u1ec7nh \u0111\u1ebfn 80% trong mu\u0300a cu\u0301m. Vi\u1ec7c ti\u00eam ng\u1eeba \u0111\u1ee7 li\u1ec1u tr\u01b0\u1edbc mu\u0300a cu\u0301m giu\u0301p cho c\u01a1 th\u1ec3 t\u0103ng s\u1ee9c \u0111\u1ec1 kh\u00e1ng, t\u0103ng c\u01b0\u1eddng s\u1ef1 mi\u1ec5n d\u1ecbch cho c\u01a1 th\u1ec3 kh\u00e1ng l\u1ea1i vi-ru\u0301t.  v\u1eafc-xin th\u01b0\u1eddng c\u00f3 v\u00e0o gi\u1eefa th\u00e1ng 9 v\u00e0 gi\u1eefa th\u00e1ng 11. M\u1eb7c du\u0300 l\u00e0 b\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 ti\u00eam ph\u00f2ng v\u1eafc-xin cu\u0301m v\u00e0o mu\u0300a cu\u0301m nh\u01b0ng t\u1ed1t h\u01a1n h\u1ebft l\u00e0 n\u00ean ti\u00eam ch\u1ee7ng s\u1edbm h\u01a1n l\u00e0 mu\u1ed9n. Tuy nhi\u00ean th\u00ec b\u1ea1n cu\u0303ng v\u1eabn n\u00ean ti\u00eam ph\u00f2ng v\u00e0o cu\u1ed1i mu\u0300a cu\u0301m.  D\u1eabu b\u1ea1n hay con b\u1ea1n \u0111\u00e3 \u0111\u01b0\u1ee3c ti\u00eam v\u1eafc-xin cu\u0301m mu\u0300a n\u0103m ngo\u00e1i r\u1ed3i th\u00ec v\u1eafc-xin cu\u0303ng c\u00f3 th\u1ec3 kh\u00f4ng giu\u0301p b\u1ea1n kh\u00f4ng b\u1ecb cu\u0301m n\u0103m nay b\u1edfi h\u00e0m l\u01b0\u1ee3ng v\u1eafc-xin trong c\u01a1 th\u1ec3 b\u1ea1n \u0111\u00e3 y\u1ebfu \u0111i v\u00e0 vi-ru\u0301t cu\u0301m bi\u1ebfn \u0111\u1ed5i li\u00ean t\u1ee5c. \u0110\u00f3 l\u00e0 l\u00fd do v\u00ec sao v\u1eafc-xin ph\u1ea3i \u0111\u01b0\u1ee3c \u0111\u1ed5i m\u1edbi h\u00e0ng n\u0103m \u0111\u1ec3 k\u00e8m th\u00eam c\u00e1c gi\u1ed1ng vi-ru\u0301t m\u1edbi nh\u1ea5t. M\u1ed9t v\u00ed d\u1ee5 minh ho\u1ea1 r\u00f5 r\u00e0ng cho th\u1ea5y c\u00e1ch vi-ru\u0301t bi\u1ebfn \u0111\u1ed5i (v\u00e0 nhi\u1ec1u khi c\u00f2n ph\u00e1t tri\u1ec3n l\u00ean th\u00e0nh m\u1ed9t gi\u1ed1ng vi-ru\u0301t m\u1edbi) l\u00e0 \u0111\u1ee3t bu\u0300ng n\u1ed5 d\u1ecbch cu\u0301m H1N1 n\u0103m 2009. Lo\u1ea1i cu\u0301m n\u00e0y kh\u00f4ng thu\u1ed9c d\u1ea1ng ch\u1ee7ng ng\u1eeba trong v\u1eafc-xin cu\u0301m mu\u0300a n\u0103m 2009-2010, th\u1ebf n\u00ean ng\u01b0\u1eddi ta \u0111\u00e3 ph\u00e1t tri\u1ec3n th\u00eam m\u1ed9t v\u1eafc-xin cu\u0301m H1N1 ri\u00eang bi\u1ec7t n\u1eefa. T\u1eeb \u0111\u00f3, cu\u0301m H1N1 \u0111\u01b0\u1ee3c ti\u00eam k\u1ebft h\u1ee3p v\u1edbi mu\u0303i ti\u00eam cu\u0301m mu\u0300a.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra Th\u01b0\u1eddng th\u00ec v\u1eafc-xin ph\u00f2ng cu\u0301m n\u00e0y \u0111\u01b0\u1ee3c ch\u00edch \u1edf vu\u0300ng tr\u00ean c\u1ee7a c\u00e1nh tay, mu\u0303i ti\u00eam ng\u1eeba cu\u0301m ch\u1ee9a vi-ru\u0301t g\u00e2y cu\u0301m \u0111\u00e3 ch\u1ebft s\u1ebd kh\u00f4ng l\u00e0m cho ng\u01b0\u1eddi \u0111\u01b0\u1ee3c ti\u00eam ph\u00f2ng m\u1eafc b\u1ec7nh m\u00e0 s\u1ebd giu\u0301p cho c\u01a1 th\u1ec3 t\u1ea1o kh\u00e1ng th\u1ec3 ch\u1ed1ng l\u1ea1i vi-ru\u0301t cu\u0301m c\u00f2n s\u1ed1ng khi chu\u0301ng x\u00e2m nh\u1eadp v\u00e0o c\u01a1 th\u1ec3. M\u1ed9t s\u1ed1 t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng th\u1ea5y nh\u1ea5t khi ti\u00eam ng\u1eeba cu\u0301m l\u00e0 \u0111au nh\u1ee9c, n\u1ed5i \u0111\u1ecf ho\u1eb7c s\u01b0ng \u1edf vu\u0300ng ti\u00eam v\u00e0 \u0111\u00f4i khi cu\u0303ng x\u1ea3y ra tr\u01b0\u1eddng h\u1ee3p \u0111au nh\u1ee9c v\u00e0 s\u1ed1t nh\u1eb9. V\u00ec v\u1eafc-xin cu\u0301m d\u1ea1ng x\u1ecbt v\u00e0o mu\u0303i du\u0300ng vi-ru\u0301t c\u00f2n s\u1ed1ng n\u00ean n\u00f3 cu\u0303ng c\u00f3 th\u1ec3 g\u00e2y ra c\u00e1c tri\u1ec7u ch\u1ee9ng gi\u1ed1ng nh\u01b0 cu\u0301m nh\u1eb9, bao g\u1ed3m s\u1ed5 mu\u0303i, nh\u1ee9c \u0111\u1ea7u, \u00f3i m\u1eeda, \u0111au nh\u1ee9c c\u01a1 v\u00e0 s\u1ed1t. R\u1ea5t hi\u1ebfm khi v\u1eafc-xin ph\u00f2ng cu\u0301m c\u00f3 th\u1ec3 g\u00e2y t\u00e1c d\u1ee5ng ph\u1ee5 nguy hi\u1ec3m nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba  Kh\u00f4ng n\u00ean ti\u00eam ng\u1eeba cu\u0301m mu\u0300a cho: * tre\u0309 s\u01a1 sinh d\u01b0\u1edbi 6 th\u00e1ng tu\u1ed5i  * ng\u01b0\u1eddi b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi tr\u1ee9ng v\u00e0 c\u00e1c s\u1ea3n ph\u1ea9m l\u00e0m t\u1eeb tr\u1ee9ng. B\u1ea1n n\u00ean cho b\u00e1c s\u0129 bi\u1ebft n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng tr\u01b0\u1edbc khi cho b\u00e9 ti\u00eam ng\u1eeba nh\u00e9. * ng\u01b0\u1eddi \u0111\u00e3 t\u1eebng b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi v\u1eafc-xin ti\u00eam ng\u1eeba cu\u0301m  * ng\u01b0\u1eddi b\u1ecb h\u1ed9i ch\u1ee9ng Guillain-Barr\u00e9 (GBS l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh hi\u1ebfm g\u1eb7p g\u00e2y \u1ea3nh  h\u01b0\u1edfng \u0111\u1ebfn th\u1ea7n kinh) * ng\u01b0\u1eddi b\u1ecb b\u1ec7nh n\u1eb7ng  Ch\u0103m s\u00f3c cho con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba  C\u00f3 th\u1ec3 du\u0300ng thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o cho th\u00edch h\u1ee3p. M\u1ed9t v\u00e0i b\u00e1c s\u0129 khuy\u1ebfn ngh\u1ecb n\u00ean s\u1eed d\u1ee5ng m\u1ed9t li\u1ec1u ngay tr\u01b0\u1edbc khi ch\u1ee7ng ng\u1eeba. B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 du\u0300ng m\u1ed9t mi\u1ebfng gi\u1ebb \u01b0\u1edbt, \u1ea5m ho\u1eb7c m\u1ed9t mi\u1ebfng l\u00f3t \u1ea5m \u0111\u1ec3 gi\u1ea3m \u0111au. Nhu\u0301c nh\u00edch, c\u1eed \u0111\u1ed9ng tay ch\u00e2n \u1edf vu\u0300ng ti\u00eam cu\u0303ng th\u01b0\u1eddng c\u00f3 t\u00e1c d\u1ee5ng gi\u1ea3m \u0111au.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc l\u00e0 n\u00ean ho\u00e3n hay tr\u00e1nh ti\u00eam lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu sau khi ti\u00eam ng\u1eeba x\u1ea3y ra nhi\u1ec1u v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng, s\u1ed1t cao, ho\u1eb7c m\u1ed9t v\u1ea5n \u0111\u1ec1 b\u1eadn t\u00e2m n\u00e0o kh\u00e1c. MMR (s\u1edfi, quai b\u1ecb, ru-b\u00ea-la) V\u1eafc-xin MMR c\u00f3 t\u00e1c d\u1ee5ng ng\u1eeba s\u1edfi, quai b\u1ecb v\u00e0 ru-b\u00ea-la. Ti\u00eam ng\u1eeba MMR \u0111\u01b0\u1ee3c chia th\u00e0nh 2 li\u1ec1u. Li\u1ec1u \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c ti\u00eam \u1edf giai \u0111o\u1ea1n t\u1eeb 12 \u0111\u1ebfn 15 th\u00e1ng tu\u1ed5i; li\u1ec1u th\u1ee9 hai th\u01b0\u1eddng t\u1eeb 4 \u0111\u1ebfn 6 tu\u1ed5i. T\u1ea1i sao ph\u1ea3i n\u00ean khuy\u1ebfn ngh\u1ecb du\u0300ng v\u1eafc-xin s\u1edfi, quai b\u1ecb v\u00e0 ru-b\u00ea-la l\u00e0 nh\u1eefng b\u1ec7nh l\u00e2y nhi\u1ec5m c\u00f3 th\u1ec3 g\u00e2y b\u1ec7nh nghi\u00eam tr\u1ecdng. H\u01a1n 95% tr\u1ebb em \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba MMR c\u00f3 th\u1ec3 mi\u1ec5n nhi\u1ec5m v\u1edbi 3 b\u1ec7nh n\u00e0y su\u1ed1t \u0111\u1eddi.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng r\u1ea5t hi\u1ebfm khi x\u1ea3y ra; nh\u01b0ng cu\u0303ng c\u00f3 th\u1ec3 g\u00e2y \u1ea3nh h\u01b0\u1edfng x\u1ea5u t\u1eeb nh\u1eb9 \u0111\u1ebfn v\u1eeba ph\u1ea3i nh\u01b0 ph\u00e1t ban, s\u1ed1t, s\u01b0ng m\u00e1/ s\u01b0ng h\u00e0m, tai bi\u1ebfn ng\u1eadp m\u00e1u v\u00e0 \u0111au kh\u1edbp nh\u1eb9. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi gelatin ho\u1eb7c v\u1edbi kh\u00e1ng sinh neomycin th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 nh\u00e9.  * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi li\u1ec1u v\u1eafc-xin MMR tr\u01b0\u1edbc * n\u1ebfu con b\u1ea1n m\u1edbi \u0111\u01b0\u1ee3c ti\u00eam gamma globulin ho\u1eb7c m\u1edbi \u0111\u01b0\u1ee3c truy\u1ec1n m\u00e1u th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 nh\u00e9. * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb m\u1ed9t b\u1ec7nh n\u00e0o \u0111\u00f3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u1ec7 mi\u1ec5n d\u1ecbch, nh\u01b0 l\u00e0 b\u1ecb ung th\u01b0 * n\u1ebfu con b\u1ea1n \u0111ang du\u0300ng thu\u1ed1c prednisone, steroids, ho\u1eb7c c\u00e1c thu\u1ed1c \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch kh\u00e1c  * n\u1ebfu con c\u1ee7a b\u1ea1n \u0111ang du\u0300ng ho\u00e1 tr\u1ecb li\u1ec7u ho\u1eb7c \u0111ang \u0111i\u1ec1u tr\u1ecb b\u1eb1ng b\u1ee9c x\u1ea1 * n\u1ebfu con b\u1ea1n t\u1eebng b\u1ecb ti\u1ec3u huy\u1ebft c\u1ea7u th\u1ea5p, b\u1ea1n h\u00e3y n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn v\u1edbi b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 nh\u00e9 * ph\u1ee5 n\u1eef c\u00f3 thai n\u00ean \u0111\u1ee3i cho \u0111\u1ebfn khi sinh xong m\u1edbi c\u00f3 th\u1ec3 ti\u00eam ng\u1eeba v\u1eafc-xin Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba N\u1ebfu b\u00e9 b\u1ecb n\u1ed5i ban m\u00e0 kh\u00f4ng c\u00f3 tri\u1ec7u ch\u1ee9ng g\u00ec kh\u00e1c th\u00ec cu\u0303ng kh\u00f4ng c\u1ea7n thi\u1ebft ph\u1ea3i ch\u1eefa tr\u1ecb g\u00ec v\u00e0 n\u00f3 s\u1ebd t\u1ef1 kh\u1ecfi trong v\u00f2ng m\u1ed9t v\u00e0i ng\u00e0y. B\u1ea1n c\u00f3 th\u1ec3 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t cho b\u00e9. N\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u b\u1ea1n n\u00ean s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p. Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc l\u00e0 c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh kh\u00f4ng ti\u00eam v\u1eafc-xin n\u1eefa * n\u1ebfu c\u00f3 v\u1ea5n \u0111\u1ec1 g\u00ec \u0111\u00f3 sau khi ti\u00eam ng\u1eeba xong B\u1ec7nh thu\u1ef7 \u0111\u1eadu  V\u1eafc-xin th\u1ee7y \u0111\u1eadu c\u00f3 t\u00e1c d\u1ee5ng ng\u1eeba th\u1ee7y \u0111\u1eadu \u2013 m\u1ed9t ch\u1ee9ng b\u1ec7nh do vi-ru\u0301t th\u01b0\u1eddng th\u1ea5y v\u00e0 r\u1ea5t hay l\u00e2y lan c\u1ee7a tr\u1ebb em. L\u1ecbch ch\u1ee7ng ng\u1eeba V\u1eafc-xin th\u1ee7y \u0111\u1eadu \u0111\u01b0\u1ee3c ti\u00eam \u1edf giai \u0111o\u1ea1n t\u1eeb 12 \u0111\u1ebfn 15 th\u00e1ng tu\u1ed5i v\u00e0 \u0111\u01b0\u1ee3c ti\u00eam nh\u1eafc l\u1ea1i t\u1eeb 4 \u0111\u1ebfn 6 tu\u1ed5i \u0111\u1ec3 ph\u00f2ng tr\u00e1nh th\u00eam cho b\u00e9. Tr\u1ebb d\u01b0\u1edbi 13 tu\u1ed5i ch\u01b0a b\u1ecb b\u1ec7nh th\u1ee7y \u0111\u1eadu cu\u0303ng c\u00f3 th\u1ec3 ti\u00eam lo\u1ea1i v\u1eafc-xin n\u00e0y v\u1edbi 2 li\u1ec1u ri\u00eang bi\u1ec7t c\u00e1ch nhau \u00edt nh\u1ea5t l\u00e0 3 th\u00e1ng. Tr\u1ebb t\u1eeb 13 tu\u1ed5i tr\u1edf l\u00ean ch\u01b0a b\u1ecb b\u1ec7nh th\u1ee7y \u0111\u1eadu ho\u1eb7c ch\u01b0a ti\u00eam ng\u1eeba v\u1eafc-xin th\u00ec cu\u0303ng c\u1ea7n ph\u1ea3i ti\u00eam 2 li\u1ec1u v\u1eafc-xin c\u00e1ch nhau \u00edt nh\u1ea5t l\u00e0 1 th\u00e1ng. T\u1ea1i sao ph\u1ea3i n\u00ean khy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin V\u1eafc-xin th\u1ee7y \u0111\u1eadu c\u00f3 t\u00e1c d\u1ee5ng ng\u0103n ng\u1eeba \u0111\u01b0\u1ee3c tr\u01b0\u1eddng h\u1ee3p b\u1ec7nh n\u1eb7ng \u1edf h\u1ea7u h\u1ebft tr\u1ebb em c\u00f3 ti\u00eam ch\u1ee7ng. V\u1eafc-xin c\u00f3 th\u1ec3 ph\u00f2ng tr\u00e1nh \u0111\u01b0\u1ee3c \u0111\u1ebfn 85% tr\u01b0\u1eddng h\u1ee3p b\u1ec7nh nhe. Nh\u1eefng tr\u1ebb em \u0111\u00e3 \u0111\u01b0\u1ee3c ch\u1ee7ng ng\u1eeba th\u01b0\u1eddng b\u1ecb thu\u1ef7 \u0111\u1eadu nh\u1eb9. R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c ph\u1ea3n \u1ee9ng nghi\u00eam tr\u1ecdng nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng l\u00e0 r\u1ea5t hi\u1ebfm. C\u00f3 th\u1ec3 x\u1ea3y ra t\u00ecnh tr\u1ea1ng \u0111au nh\u1ee9c nh\u1eb9 v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam, s\u1ed1t, m\u1ec7t m\u1ecfi, v\u00e0 b\u1ec7nh gi\u1ed1ng nh\u01b0 thu\u1ef7 \u0111\u1eadu. Ch\u1ee9ng ph\u00e1t ban c\u00f3 th\u1ec3 x\u1ea3y ra 1 th\u00e1ng sau khi ti\u00eam; c\u00f3 th\u1ec3 k\u00e9o d\u00e0i v\u00e0i ng\u00e0y nh\u01b0ng s\u1ebd t\u1ef1 kh\u1ecfi m\u00e0 kh\u00f4ng c\u1ea7n ph\u1ea3i ch\u1eefa tr\u1ecb g\u00ec. R\u1ea5t hi\u1ebfm khi x\u1ea3y ra tai bi\u1ebfn ng\u1eadp m\u00e1u do s\u1ed1t sau khi ti\u00eam ng\u1eeba v\u1eafc-xin.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi gelatin ho\u1eb7c v\u1edbi kh\u00e1ng sinh neomycin  * n\u1ebfu con b\u1ea1n b\u1ecb ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi li\u1ec1u v\u1eafc-xin th\u1ee7y \u0111\u1eadu tr\u01b0\u1edbc * n\u1ebfu con b\u1ea1n m\u1edbi \u0111\u01b0\u1ee3c ti\u00eam gamma globulin ho\u1eb7c m\u1edbi \u0111\u01b0\u1ee3c truy\u1ec1n m\u00e1u, b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ti\u00eam ng\u1eeba cho b\u00e9 nh\u00e9 * n\u1ebfu con b\u1ea1n b\u1ecb b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u1ec7 mi\u1ec5n d\u1ecbch, nh\u01b0 l\u00e0 b\u1ecb ung th\u01b0 ch\u1eb3ng h\u1ea1n; n\u1ebfu b\u00e9 \u0111ang du\u0300ng prednisone, steroids, ho\u1eb7c c\u00e1c thu\u1ed1c \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch kh\u00e1c; ho\u1eb7c \u0111ang du\u0300ng ho\u00e1 tr\u1ecb li\u1ec7u ho\u1eb7c \u0111ang \u0111i\u1ec1u tr\u1ecb b\u1eb1ng b\u1ee9c x\u1ea1 * ph\u1ee5 n\u1eef c\u00f3 thai n\u00ean \u0111\u1ee3i cho \u0111\u1ebfn khi sinh xong m\u1edbi c\u00f3 th\u1ec3 ti\u00eam ng\u1eeba v\u1eafc-xin Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba  B\u1ea1n c\u00f3 th\u1ec3 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t cho b\u00e9. N\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng lo\u1ea1i thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p. Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc l\u00e0 li\u1ec7u n\u00ean ho\u00e3n hay tr\u00e1nh ti\u00eam lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec sau khi ch\u1ee7ng ng\u1eeba MCV4 V\u1eafc-xin vi\u00eam m\u00e0ng n\u00e3o c\u00f3 t\u00e1c d\u1ee5ng ng\u0103n ng\u1eeba b\u1ec7nh do khu\u1ea9n c\u1ea7u m\u00e0ng n\u00e3o g\u00e2y ra, \u0111\u00e2y l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh nhi\u1ec5m khu\u1ea9n nghi\u00eam tr\u1ecdng c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn vi\u00eam m\u00e0ng n\u00e3o do vi khu\u1ea9n. V\u1eafc-xin \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho tr\u1ebb t\u1eeb 11 \u0111\u1ebfn 12 tu\u1ed5i, tr\u1ebb t\u1eeb 13 \u0111\u1ebfn 18 tu\u1ed5i ch\u01b0a \u0111\u01b0\u1ee3c ti\u00eam ch\u1ee7ng tr\u01b0\u1edbc \u0111\u00e2y v\u00e0 thi\u1ebfu ni\u00ean l\u1edbn tu\u1ed5i h\u01a1n s\u1eafp v\u00e0o \u0111\u1ea1i h\u1ecdc v\u00e0 s\u1ed1ng \u1edf m\u00f4i tr\u01b0\u1eddng t\u1eadp th\u1ec3 v\u00e0 nh\u1eefng ng\u01b0\u1eddi s\u1eafp nh\u1eadp ngu\u0303. V\u1eafc- xin n\u00e0y cu\u0303ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho tr\u1ebb t\u1eeb 2 \u0111\u1ebfn 10 tu\u1ed5i c\u00f3 nguy c\u01a1 nhi\u1ec5m b\u1ec7nh cao. Khi b\u1ec7nh c\u00f2n ti\u1ebfp t\u1ee5c th\u00ec nh\u1eefng tr\u1ebb em n\u00e0y cu\u0303ng c\u1ea7n th\u00eam m\u1ed9t li\u1ec1u ti\u00eam nh\u1eafc sau m\u1ed9t v\u00e0i n\u0103m, tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i b\u00e9 khi \u0111\u01b0\u1ee3c ti\u00eam ch\u00edch mu\u0303i \u0111\u1ea7u ti\u00ean. T\u1ea1i sao ph\u1ea3i n\u00ean khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin Vi\u00eam m\u00e0ng n\u00e3o do vi khu\u1ea9n l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh vi\u00eam m\u00e0ng b\u1ea3o v\u1ec7 n\u00e3o v\u00e0 tu\u1ef7 s\u1ed1ng, l\u00e0 m\u1ed9t b\u1ec7nh hi\u1ebfm g\u1eb7p nh\u01b0ng r\u1ea5t hay l\u00e2y lan c\u00f3 th\u1ec3 l\u00e2y lan nhanh t\u1eeb tr\u1ebb n\u00e0y sang tr\u1ebb kh\u00e1c trong vu\u0300ng l\u00e2n c\u1eadn. B\u1ec7nh n\u00e0y c\u00f3 th\u1ec3 nguy hi\u1ec3m \u0111\u1ebfn t\u00ednh m\u1ea1ng n\u1ebfu kh\u00f4ng \u0111\u01b0\u1ee3c ch\u1eefa tr\u1ecb k\u1ecbp th\u1eddi.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra M\u1ed9t s\u1ed1 t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng th\u1ea5y nh\u1ea5t l\u00e0 da b\u1ecb s\u01b0ng, n\u1ed5i \u0111\u1ecf v\u00e0 \u0111au nh\u1ee9c \u1edf vu\u0300ng ti\u00eam, cu\u0300ng v\u1edbi tri\u1ec7u ch\u1ee9ng nh\u1ee9c \u0111\u1ea7u, s\u1ed1t, ho\u1eb7c m\u1ec7t m\u1ecfi. C\u00e1c v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng r\u1ea5t hi\u1ebfm x\u1ea3y ra. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111\u00e3 t\u1eebng ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin DtaP ho\u1eb7c d\u1ecb \u1ee9ng v\u1edbi nh\u1ef1a m\u1ee7 * n\u1ebfu con b\u1ea1n c\u00f3 ti\u1ec1n s\u1eed h\u1ed9i ch\u1ee9ng Guillain-Barr\u00e9, \u0111\u00e2y l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh c\u1ee7a h\u1ec7 th\u1ea7n kinh l\u00e0m k\u00e9m ph\u00e1t tri\u1ec3n  * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba Con b\u1ea1n c\u00f3 th\u1ec3 b\u1ecb s\u1ed1t, \u0111au nh\u1ee9c ho\u1eb7c da b\u1ecb s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. B\u1ea1n c\u00f3 th\u1ec3 cho b\u00e9 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. H\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u n\u00ean s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p nh\u00e9.  B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 gi\u1ea3m \u0111au b\u1eb1ng m\u1ed9t mi\u1ebfng gi\u1ebb \u01b0\u1edbt, \u1ea5m. Nhu\u0301c nh\u00edch, c\u1eed \u0111\u1ed9ng tay ch\u00e2n vu\u0300ng ti\u00eam cu\u0303ng th\u01b0\u1eddng giu\u0301p gi\u1ea3m \u0111au nh\u1ee9c.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft li\u1ec7u n\u00ean ho\u00e3n hay tr\u00e1nh ti\u00eam lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec sau khi ti\u00eam ng\u1eeba B\u1ec7nh vi\u00eam gan si\u00eau vi A Vi-ru\u0301t vi\u00eam gan si\u00eau vi A (HAV) g\u00e2y ra s\u1ed1t, bu\u1ed3n n\u00f4n, \u00f3i m\u1eeda, v\u00e0ng da, v\u00e0 c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn \u0111\u1ea1i d\u1ecbch trong c\u1ed9ng \u0111\u1ed3ng. Nh\u1eefng trung t\u00e2m ch\u0103m s\u00f3c v\u00e0 gi\u00e1m s\u00e1t tr\u1ebb em th\u01b0\u1eddng l\u00e0 n\u01a1i bu\u0300ng ph\u00e1t b\u1ec7nh vi\u00eam gan si\u00eau vi A.  V\u1eafc-xin vi\u00eam gan si\u00eau vi A \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho tr\u1ebb t\u1eeb 12 \u0111\u1ebfn 23 th\u00e1ng tu\u1ed5i v\u00e0 ti\u00eam th\u00eam li\u1ec1u th\u1ee9 hai sau 6 th\u00e1ng. M\u1eb7c du\u0300 lu\u0301c tr\u01b0\u1edbc lo\u1ea1i v\u1eafc-xin n\u00e0y \u0111\u01b0\u1ee3c khuy\u1ebfn c\u00e1o cho tr\u1ebb l\u1edbn tu\u1ed5i h\u01a1n v\u00e0 ng\u01b0\u1eddi l\u1edbn c\u00f3 nguy c\u01a1 nhi\u1ec5m b\u1ec7nh cao (nh\u01b0 ng\u01b0\u1eddi s\u1ed1ng ho\u1eb7c \u0111\u1ebfn c\u00e1c vu\u0300ng c\u00f3 t\u1ec9 l\u1ec7 ng\u01b0\u1eddi m\u1eafc HAV cao), ng\u00e0y nay v\u1eafc-xin n\u00e0y \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho t\u1ea5t c\u1ea3 m\u1ecdi ng\u01b0\u1eddi c\u00f3 nhu c\u1ea7u mu\u1ed1n mi\u1ec5n d\u1ecbch v\u1edbi b\u1ec7nh. T\u1ea1i sao ph\u1ea3i n\u00ean khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin Ti\u00eam ng\u1eeba HAV kh\u00f4ng nh\u1eefng giu\u0301p ng\u0103n ch\u1eb7n d\u1ecbch b\u1ec7nh lan r\u1ed9ng trong c\u1ed9ng \u0111\u1ed3ng m\u00e0 c\u00f2n giu\u0301p ph\u00f2ng tr\u00e1nh b\u1ec7nh cho t\u1eebng \u0111\u1ee9a tr\u1ebb m\u1ed9t. M\u1ed9t s\u1ed1 tr\u1ebb b\u1ecb nhi\u1ec5m b\u1ec7nh kh\u00f4ng c\u00f3 b\u1ea5t k\u1ef3 tri\u1ec7u ch\u1ee9ng g\u00ec v\u00e0 c\u00f3 th\u1ec3 l\u00e2y vi-ru\u0301t cho nh\u1eefng \u0111\u1ee9a tr\u1ebb kh\u00e1c. c\u00e0ng nhi\u1ec1u tr\u1ebb em \u0111\u01b0\u1ee3c ti\u00eam ch\u1ee7ng HAV th\u00ec b\u1ec7nh s\u1ebd \u00edt l\u00e2y lan trong c\u1ed9ng \u0111\u1ed3ng h\u01a1n.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng g\u1eb7p l\u00e0 s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c, da b\u1ecb s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. R\u1ea5t hi\u1ebfm khi x\u1ea3y ra tr\u01b0\u1eddng h\u1ee3p ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi li\u1ec1u v\u1eafc-xin vi\u00eam gan si\u00eau vi A \u0111\u1ea7u ti\u00ean  Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba Con b\u1ea1n c\u00f3 th\u1ec3 b\u1ecb s\u1ed1t, \u0111au nh\u1ee9c, da b\u1ecb s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. B\u1ea1n c\u00f3 th\u1ec3 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t cho b\u00e9. N\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p cho b\u00e9 nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129 * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh ch\u1ee7ng ng\u1eeba v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec \u0111\u00f3 sau khi ch\u1ee7ng ng\u1eeba Vi ru\u0301t g\u00e2y b\u1ec7nh vi\u00eam ru\u1ed9t v\u00e0 d\u1ea1 d\u00e0y Vi ru\u0301t g\u00e2y b\u1ec7nh vi\u00eam ru\u1ed9t v\u00e0 d\u1ea1 d\u00e0y l\u00e0 vi-ru\u0301t th\u01b0\u1eddng th\u1ea5y g\u00e2y b\u1ec7nh ti\u00eau ch\u1ea3y, nh\u1ea5t l\u00e0 \u0111\u1ed1i v\u1edbi tr\u1ebb s\u01a1 sinh v\u00e0 tr\u1ebb nh\u1ecf. C\u00e1c trung t\u00e2m ch\u0103m s\u00f3c v\u00e0 gi\u00e1m s\u00e1t tr\u1ebb em th\u01b0\u1eddng l\u00e0 nh\u1eefng n\u01a1i bu\u0300ng ph\u00e1t d\u1ecbch b\u1ec7nh. V\u1eafc-xin n\u00e0y \u1edf d\u1ea1ng ch\u1ea5t l\u1ecfng v\u00e0 \u0111\u01b0\u1ee3c du\u0300ng \u0111\u01b0\u1eddng u\u1ed1ng; \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho tr\u1ebb t\u1eeb 2 \u0111\u1ebfn 4 th\u00e1ng tu\u1ed5i, cu\u0303ng nh\u01b0 1 li\u1ec1u \u1edf giai \u0111o\u1ea1n 6 th\u00e1ng tu\u1ed5i tu\u1ef3 thu\u1ed9c v\u00e0o lo\u1ea1i v\u1eafc-xin \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba.  T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin Vi ru\u0301t g\u00e2y b\u1ec7nh vi\u00eam ru\u1ed9t v\u00e0 d\u1ea1 d\u00e0y c\u00f3 th\u1ec3 g\u00e2y m\u1ea5t n\u01b0\u1edbc th\u1ee9 ph\u00e1t \u0111\u1ebfn ti\u00eau ch\u1ea3y n\u1eb7ng v\u00e0 c\u00f3 th\u1ec3 b\u1eaft tr\u1ebb ph\u1ea3i nh\u1eadp vi\u1ec7n. Vi\u1ec7c ch\u1ee7ng ng\u1eeba vi ru\u0301t g\u00e2y b\u1ec7nh vi\u00eam ru\u1ed9t v\u00e0 d\u1ea1 d\u00e0y c\u00f3 th\u1ec3 giu\u0301p ng\u0103n ch\u1eb7n l\u00e2y lan trong c\u1ed9ng \u0111\u1ed3ng v\u00e0 giu\u0301p ph\u00f2ng tr\u00e1nh b\u1ec7nh cho t\u1eebng tr\u1ebb m\u1ed9t.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng g\u1eb7p l\u00e0 ti\u00eau ch\u1ea3y, \u00f3i m\u1eeda v\u00e0 s\u1ed1t.  K hi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 th\u00ec cu\u0303ng kh\u00f4ng n\u00ean ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi li\u1ec1u v\u1eafc-xin tr\u01b0\u1edbc * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi nh\u1ef1a m\u1ee7 th\u00ec b\u1ea1n n\u00ean th\u00f4ng b\u00e1o cho b\u00e1c s\u0129 bi\u1ebft  * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb t\u1eadt v\u1ec1 h\u1ec7 ti\u00eau ho\u00e1 ho\u1eb7c b\u1ec7nh d\u1ea1 d\u00e0y-ru\u1ed9t th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 nh\u00e9 * n\u1ebfu con b\u1ea1n c\u00f3 ti\u1ec1n s\u1eed l\u1ed3ng ru\u1ed9t, m\u1ed9t b\u1ec7nh t\u1eaft ngh\u1ebdn ru\u1ed9t nghi\u00eam tr\u1ecdng th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 * n\u1ebfu con b\u1ea1n m\u1edbi \u0111\u01b0\u1ee3c ti\u00eam gamma globulin ho\u1eb7c m\u1edbi \u0111\u01b0\u1ee3c truy\u1ec1n m\u00e1u * n\u1ebfu con b\u1ea1n c\u00f3 v\u1ea5n \u0111\u1ec1 v\u1ec1 h\u1ec7 mi\u1ec5n d\u1ecbch nh\u01b0 b\u1ecb ung th\u01b0 ch\u1eb3ng h\u1ea1n; n\u1ebfu b\u00e9 \u0111ang du\u0300ng thu\u1ed1c steroid hay c\u00e1c thu\u1ed1c \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch kh\u00e1c; ho\u1eb7c b\u00e9 \u0111ang du\u0300ng ho\u00e1 tr\u1ecb li\u1ec7u ho\u1eb7c \u0111ang \u0111i\u1ec1u tr\u1ecb b\u1eb1ng b\u1ee9c x\u1ea1 Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n m\u00e0 b\u00e1c s\u0129 c\u00f3 th\u1ec3 cho acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. H\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 bi\u1ebft xem c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p. N\u1ebfu b\u00e9 b\u1ecb \u00f3i m\u1eeda ho\u1eb7c ti\u00eau ch\u1ea3y th\u00ec ph\u1ea3i \u0111\u1ea3m b\u1ea3o n\u00ean cho b\u00e9 u\u1ed1ng n\u01b0\u1edbc th\u01b0\u1eddng xuy\u00ean v\u00e0 theo d\u00f5i xem b\u00e9 c\u00f3 d\u1ea5u hi\u1ec7u m\u1ea5t n\u01b0\u1edbc kh\u00f4ng, ch\u1eb3ng h\u1ea1n nh\u01b0 n\u01b0\u1edbc ti\u1ec3u \u00edt h\u01a1n b\u00ecnh th\u01b0\u1eddng.  Khi n\u00e0o n\u00ean g\u1ecdi \u0111i\u1ec7n cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh ch\u1ee7ng ng\u1eeba lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec \u0111\u00f3 sau khi ch\u1ee7ng ng\u1eeba HPV Vi-ru\u0301t g\u00e2y b\u1ec7nh m\u1ee5n c\u01a1m tr\u00ean ng\u01b0\u1eddi (HPV) l\u00e0 b\u1ec7nh l\u00e2y truy\u1ec1n qua \u0111\u01b0\u1eddng t\u00ecnh d\u1ee5c (STD) g\u00e2y n\u1ed5i m\u1ee5n c\u00f3c \u1edf b\u1ed9 ph\u1eadn sinh d\u1ee5c v\u00e0 g\u00e2y ra nh\u1eefng thay \u0111\u1ed5i trong c\u1ed5 t\u1eed cung c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn ung th\u01b0 c\u1ed5 t\u1eed cung. V\u1eafc-xin \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba th\u00e0nh m\u1ed9t lo\u1ea1t 3 mu\u0303i trong v\u00f2ng 6 th\u00e1ng v\u00e0 \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho b\u00e9 g\u00e1i t\u1eeb 11 ho\u1eb7c 12 tu\u1ed5i, cu\u0303ng nh\u01b0 c\u00e1c b\u00e9 g\u00e1i l\u1edbn tu\u1ed5i h\u01a1n ch\u01b0a \u0111\u01b0\u1ee3c ti\u00eam ch\u1ee7ng. Lo\u1ea1i v\u1eafc-xin n\u00e0y cu\u0303ng \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng cho b\u00e9 trai t\u1eeb 9 \u0111\u1ebfn 18 tu\u1ed5i nh\u1eb1m ph\u00f2ng tr\u00e1nh ch\u1ee9ng n\u1ed5i m\u1ee5n c\u00f3c \u1edf b\u1ed9 ph\u1eadn sinh d\u1ee5c. T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin  V\u00ec vi-ru\u0301t HPV c\u00f3 th\u1ec3 g\u00e2y nhi\u1ec1u v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng nh\u01b0 n\u1ed5i m\u1ee5n c\u00f3c \u1edf b\u1ed9 ph\u1eadn sinh d\u1ee5c v\u00e0 ung th\u01b0 c\u1ed5 t\u1eed cung, n\u00ean v\u1eafc-xin l\u00e0 m\u1ed9t bi\u1ec7n ph\u00e1p quan tr\u1ecdng nh\u1eb1m ph\u00f2ng tr\u00e1nh l\u00e2y nhi\u1ec5m v\u00e0 ng\u0103n ng\u1eeba l\u00e2y lan HPV. V\u1eafc-xin n\u00e0y c\u00f3 hi\u1ec7u qu\u1ea3 t\u1ed1t nh\u1ea5t n\u1ebfu ti\u00eam ng\u1eeba cho b\u00e9 g\u00e1i tr\u01b0\u1edbc khi quan h\u1ec7 t\u00ecnh d\u1ee5c.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng g\u1eb7p l\u00e0 s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c, da s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam; cu\u0303ng c\u00f3 th\u1ec3 b\u1ecb ch\u00f3ng m\u1eb7t, cho\u00e1ng v\u00e1ng, bu\u1ed3n n\u00f4n v\u00e0 \u00f3i m\u1eeda sau khi ti\u00eam ng\u1eeba. Tr\u01b0\u1eddng h\u1ee3p d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin r\u1ea5t hi\u1ebfm khi x\u1ea3y ra.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n \u0111\u00e3 b\u1ecb d\u1ecb \u1ee9ng v\u1edbi li\u1ec1u v\u1eafc-xin HPV \u0111\u1ea7u ti\u00ean * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n \u0111\u00e3 b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi men (r\u01b0\u1ee3u bia) * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n \u0111ang c\u00f3 thai * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n b\u1ecb b\u1ec7nh m\u00e1u lo\u00e3ng (b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 chuy\u00ean khoa huy\u1ebft h\u1ecdc nh\u00e9) Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba Con c\u1ee7a b\u1ea1n c\u00f3 th\u1ec3 b\u1ecb s\u1ed1t, \u0111au nh\u1ee9c, da s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. B\u1ea1n c\u00f3 th\u1ec3 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t cho b\u00e9. H\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh ch\u1ee7ng ng\u1eeba lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec sau khi ch\u1ee7ng ng\u1eeba L\u1ecbch ch\u1ee7ng ng\u1eeba L\u1ecbch ch\u1ee7ng ng\u1eeba n\u00e0y l\u00e0 b\u1ea3ng tham kh\u1ea3o ti\u1ec7n l\u1ee3i c\u00f3 th\u1ec3 giu\u0301p cho b\u1ea1n theo d\u00f5i \u0111\u01b0\u1ee3c c\u00e1c lo\u1ea1i v\u1eafc-xin c\u1ea7n thi\u1ebft v\u1edbi con m\u00ecnh v\u00e0 th\u1eddi gian ti\u00eam ng\u1eeba cho b\u00e9.  C\u00e1c lo\u1ea1i v\u1eafc-xin M\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin th\u01b0\u1eddng g\u1eb7p: 1. Vi-ru\u0301t c\u00f2n s\u1ed1ng nh\u01b0ng \u0111\u00e3 b\u1ecb l\u00e0m y\u1ebfu \u0111i \u0111\u01b0\u1ee3c du\u0300ng trong m\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin nh\u01b0 v\u1eafc-xin s\u1edfi, ru-b\u00ea-la v\u00e0 quai b\u1ecb.  2. Vi-ru\u0301t ho\u1eb7c vi khu\u1ea9n \u0111\u00e3 ch\u1ebft (ho\u1eb7c b\u1ea5t ho\u1ea1t) \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng trong m\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin nh\u01b0 v\u1eafc-xin IPV. 3. V\u1eafc-xin gi\u1ea3i \u0111\u1ed9c t\u1ed1 ch\u1ee9a \u0111\u1ed9c t\u1ed1 t\u00f4-xin b\u1ea5t ho\u1ea1t do vi khu\u1ea9n t\u1ea1o ra. Ch\u1eb3ng h\u1ea1n nh\u01b0 v\u1eafc-xin b\u1ea1ch h\u1ea7u v\u00e0 u\u1ed1n v\u00e1n l\u00e0 c\u00e1c v\u1eafc-xin gi\u1ea3i \u0111\u1ed9c t\u1ed1. 4. V\u1eafc-xin k\u1ebft h\u1ee3p (nh\u01b0 Hib) ch\u1ee9a c\u00e1c th\u00e0nh ph\u1ea7n vi khu\u1ea9n k\u1ebft h\u1ee3p v\u1edbi pr\u00f4-t\u00ea-in. Ch\u1ee7ng ng\u1eeba khi \u0111i du l\u1ecbch C\u00e1c Trung t\u00e2m ph\u00f2ng ch\u1ed1ng b\u1ec7nh t\u1eadt (CDC) s\u1ebd cung c\u1ea5p tr\u1ef1c ti\u1ebfp th\u00f4ng tin c\u1ee5 th\u1ec3 v\u1ec1 ch\u1ee7ng ng\u1eeba cho kh\u00e1ch du l\u1ecbch \u0111\u1ebfn t\u1eebng qu\u1ed1c gia tr\u00ean to\u00e0n c\u1ea7u. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 bi\u1ebft th\u00eam th\u00f4ng tin nh\u00e9. Tu\u0300y thu\u1ed9c v\u00e0o lo\u1ea1i h\u00ecnh du l\u1ecbch v\u00e0 th\u1eddi gian \u0111i du l\u1ecbch m\u00e0 ng\u01b0\u1eddi ta khuy\u1ebfn ngh\u1ecb n\u00ean s\u1eed d\u1ee5ng m\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin. H\u1ea7u h\u1ebft c\u00e1c v\u1eafc-xin ch\u1ee7ng ng\u1eeba \u0111\u1ec1u \u0111\u01b0\u1ee3c ti\u00eam tr\u01b0\u1edbc khi \u0111i du l\u1ecbch \u00edt nh\u1ea5t l\u00e0 1 th\u00e1ng. B\u1ea1n n\u00ean mang theo h\u1ed3 s\u01a1 ch\u1ee7ng ng\u1eeba c\u1ee7a b\u00e9 b\u1ea5t k\u1ec3 khi n\u00e0o b\u1ea1n \u0111i du l\u1ecbch qu\u1ed1c t\u1ebf nh\u00e9. Giu\u0301p tr\u1ebb v\u01b0\u1ee3t qua n\u1ed7i s\u1ee3 h\u00e3i ch\u1ee7ng ng\u1eeba Nhi\u1ec1u khi kh\u00f3 bi\u1ebft \u0111\u01b0\u1ee3c gi\u1eefa b\u1ed1 m\u1eb9 v\u00e0 tr\u1ebb con - ai l\u00e0 ng\u01b0\u1eddi s\u1ee3 ch\u1ee7ng ng\u1eeba h\u01a1n. D\u01b0\u1edbi \u0111\u00e2y l\u00e0 m\u1ed9t s\u1ed1 b\u00ed quy\u1ebft giu\u0301p cho quy tr\u00ecnh ti\u00eam ch\u1ee7ng tr\u1edf n\u00ean d\u1ec5 d\u00e0ng cho t\u1ea5t c\u1ea3 m\u1ecdi ng\u01b0\u1eddi. * H\u00e3y n\u00f3i cho nh\u1eefng tr\u1ebb l\u1edbn tu\u1ed5i h\u01a1n bi\u1ebft chuy\u1ec7n g\u00ec s\u1ebd x\u1ea3y ra v\u00e0 ti\u00eam ng\u1eeba c\u00f3 th\u1ec3 giu\u0301p chu\u0301ng kho\u1ebb m\u1ea1nh h\u01a1n * H\u00e3y n\u00f3i v\u1edbi tr\u1ebb nh\u1ecf l\u00e0 n\u1ebfu b\u00e9 kh\u00f3c th\u00ec cu\u0303ng \u0111\u01b0\u1ee3c th\u00f4i nh\u01b0ng b\u1ea1n cu\u0303ng n\u00ean khuy\u1ebfn kh\u00edch chu\u0301ng h\u00e3y can \u0111\u1ea3m l\u00ean. * B\u1ea1n h\u00e3y t\u1ecf ra b\u00ecnh t\u0129nh nh\u00e9. Con c\u1ee7a b\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 \u0111\u1ec3 \u00fd \u0111\u01b0\u1ee3c m\u1ed1i lo l\u1eafng c\u1ee7a b\u1ea1n \u0111\u1ea5y. * Vi\u1ec7c l\u00e0m cho b\u00e9 ph\u00e2n t\u00e2m lu\u0301c n\u00e0y cu\u0303ng c\u00f3 t\u00e1c d\u1ee5ng t\u1ed1t. B\u1ea1n h\u00e3y th\u1eed cho b\u00e9 \u0111\u1ebfm, cu\u0300ng h\u00e1t m\u1ed9t b\u00e0i h\u00e1t v\u1edbi b\u1ea1n, ho\u1eb7c nh\u00ecn sang ch\u1ed7 kh\u00e1c (c\u00f3 th\u1ec3 nh\u00ecn m\u1ed9t b\u1ee9c tranh tr\u00ean t\u01b0\u1eddng). B\u1ea1n cu\u0303ng n\u00ean chu\u1ea9n b\u1ecb s\u1eb5n m\u1ed9t chuy\u1ec7n \u0111u\u0300a ho\u1eb7c m\u1ed9t l\u1eddi n\u00f3i d\u00ed d\u1ecfm n\u00e0o \u0111\u00f3 cho b\u00e9 nh\u00e9. * H\u00e3y khen b\u00e9 sau khi \u0111\u00e3 ti\u00eam ng\u1eeba xong. * B\u1ea1n n\u00ean chu\u1ea9n b\u1ecb m\u1ed9t vi\u1ec7c g\u00ec \u0111\u00f3 vui v\u1ebb sau khi b\u00e9 ch\u00edch ng\u1eeba xong. M\u1ed9t chuy\u1ebfn \u0111i c\u00f4ng vi\u00ean hay ch\u01a1i \u1edf s\u00e2n ch\u01a1i cu\u0303ng c\u00f3 th\u1ec3 l\u00e0m cho cu\u1ed9c ti\u00eam ng\u1eeba tr\u1edf n\u00ean d\u1ec5 ch\u1ecbu h\u01a1n.  Vi\u1ec7c ti\u00eam ch\u1ee7ng c\u00f3 th\u1ec3 khi\u1ebfn cho c\u1ea3 b\u1ea1n v\u00e0 con b\u1ea1n c\u1ea3m th\u1ea5y kh\u00f4ng tho\u1ea3i m\u00e1i t\u00ed n\u00e0o, nh\u01b0ng xin nh\u1edb r\u1eb1ng ch\u1ee7ng ng\u1eeba l\u00e0 m\u1ed9t trong nh\u1eefng bi\u1ec7n ph\u00e1p b\u1ea3o v\u1ec7 t\u1ed1t nh\u1ea5t giu\u0301p ph\u00f2ng tr\u00e1nh c\u00e1c b\u1ec7nh l\u00e2y nhi\u1ec5m."
        }
    ],
    "suggestions": []
}